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Expanded electronic transfer of data 
in the National Infectious Diseases Register 
The year 2004 was the tenth full year of operation 
for the National Infectious Diseases Register. When 
the register was established, its operating princi-
ples were advanced even by international stand-
ards: microbiological laboratories notify their fi nd-
ings directly to the national register, and are linked 
with the complementary data notifi ed by the treat-
ing physicians for a number of diseases under sur-
veillance.
The basic concepts regarding the operation of 
the register have proved effi cient. Especially the In-
ternet contributed to the development of electronic 
information management and data transfer meth-
ods. On the other hand, the information need of 
the personnel responsible for the regional and local 
surveillance and prevention of infectious diseases 
increased. This has rapidly changed the operating 
environment and requires continuous development.
As the operating environment has changed, 
the objective of the National Infectious Diseases 
Register has also shifted from the surveillance of 
long-term trends to supporting the rapid detec-
tion and control of regional epidemics. The chang-
ing objective requires rapid communication to the 
personnel responsible for infectious disease con-
trol in hospital districts and health centres. This has 
been enabled by increased direct electronic noti-
fying from the microbiological laboratories to the 
National Infectious Diseases Register. The hospital 
districts (from the beginning of 2004 also the health 
centres) can use encrypted Internet connection for 
access to all data concerning their respective re-
gions in the national register, and this has also 
speeded up the communication process. In the be-
ginning of 2004, the operation of the National Infec-
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tious Diseases Register’s strain collection became 
statutory. The purpose of the strain collection is to 
obtain strains of important pathogens, for confi rm-
ing identifi cation and to perform various typings 
and susceptibility assays. These data are also avail-
able for those responsible for infectious disease 
control and prevention. As a whole, the system is 
unique internationally.
Improved quality of data
The range of infectious diseases under surveillance 
is wide, comprising approximately 70 diseases or 
pathogens and all microbial fi ndings in blood and 
cerebrospinal fl uid. Unique person identifying num-
bers have been employed in the entire National 
Infectious Diseases Register since the beginning 
of 2004. This ensures reliable linking of data ob-
tained on the same case from different sources, as 
well as reliable geographical locating of cases with 
the help of the data available in the Population In-
formation System. The use of the unique person 
identifying number enables versatile population-
based research on a range of infectious diseases 
that is uniquely wide internationally, exploiting also 
Finland’s other high-quality health care registers. 
Comprehensive statistical data recorded in the 
National Infectious Diseases Register are available 
to the public at http://www.ktl.fi /ttr.
As regards the quality of data in the Nation-
al Infectious Diseases Register and the function-
ing of the system, immediate notifi cation of fi nd-
ings by microbiological laboratories is critical, as is 
the work of the personnel responsible for infectious 
diseases in the hospital districts, who check and 
complete the physicians’ notifi cations before they 
are submitted to the national register.
EPIDEMIOLOGICAL KEY EVENTS 
IN THE TEN-YEAR PERIOD
Vaccine-preventable diseases have decreased
Since the establishment of the National Infectious 
Diseases Register, three diseases have disappeared 
from Finland due to vaccinations. Endemic MMR 
cases (measles, mumps, rubella) have not been di-
agnosed since the mid-1990s. Only sporadic cases 
have been detected in nonvaccinated people, re-
lated to travelling. Diseases caused by Haemophilus
infl uenzae type b (Hib) decreased rapidly due to Hib 
vaccinations started in 1986. There have been sev-
eral years with no Hib cases being diagnosed in 
vaccinated age groups. The incidence of tuberculo-
sis cases has halved during the last ten years, which 
is mainly due to the shrinking age groups that were 
born before World War II and are susceptible to the 
reactivation of tuberculosis.
New whooping cough vaccine 
The incidence of whooping cough, a vaccine-pre-
ventable disease, has increased. In 2004, the inci-
dence was clearly the highest in the surveillance 
period, which has caused concern over the effi cacy 
of the vaccination programme. A whooping cough 
vaccine booster was added to the vaccination pro-
gramme in 2003, administered right before the child 
starts school. Since the beginning of 2005, a cell-
free whooping cough vaccine has been in use as a 
component in a new combination vaccine.
Effective preventive measures against drug abuse
Acute hepatitis B cases, new hepatitis C cases and 
HIV cases related to injecting drugs have started 
to decrease. This supports the perception that the 
I N F E C T I O U S  D I S E A S E S  I N  F I N L A N D  1 9 9 5  2 0 0 4
7
preventive measures to decrease drug abuse and 
particularly to reduce the harm from infections re-
lated to drugs have been effi cient. Low-threshold 
counselling centres for the exchange of needles and 
syringes have been established in different parts of 
Finland. In 2002–2003, there was a large outbreak 
of hepatitis A in different parts of Finland, mainly 
among injecting drug users. The extensive target-
ed vaccination programme that was executed then 
evidently had a central role in suppressing the out-
break.
Chlamydia still the most common sexually 
transmitted disease among the young
Sexually transmitted Chlamydia infection, clear-
ly the most common disease in the Infectious Dis-
eases Register by the number of cases (more than 
13,000 cases a year; about a quarter of all notifi ed 
cases in the register) has continued to increase un-
til recent years. Now the situation may be stabilis-
ing. Chlamydia infections often have chronic con-
sequences, which renders the disease a massive 
challenge to public health work.
Reinforcing the communication in outbreak 
investigations
During the last ten years much effort has been put 
into reinforcing communication during outbreaks 
and into strengthening investigation. Several 
campylobacter outbreaks transmitted via water dis-
tribution systems occurred before the 2000s. Since 
the latter half of the 1990s Yersinia has become a 
major cause of outbreaks. In various outbreak in-
vestigations fresh produce, like iceberg lettuce or 
grated carrot, has been identifi ed as the vehicle. 
New guidelines have been provided recently aiming 
to prevent such cases.
Increasing MRSA outbreaks
Finland’s antimicrobial susceptibility situation was 
internationally favourable until the beginning of the 
2000s. Recurrent MRSA epidemics have changed 
the situation in recent years. During the last two 
years, the percentage of MRSA strains in Staphy-
lococcus aureus fi ndings from blood has increased 
rapidly. The macrolide resistance of pneumococ-
cal strains detected in blood and cerebrospinal fl uid 
has increased rapidly in a few years, and the per-
centage of strains with reduced susceptibility to 
penicillin is also considerable. This unfavourable 
development requires effi cient measures focuss-
ing on more restricted use of antimicrobials and re-
inforcing the prevention of hospital infections, in 
order to reverse the negative trend before it is too 
late.
Helsinki 10 June 2005
Petri Ruutu 
Chief, Surveillance and Epidemiological 
Investigations
Pekka Puska
Director General of the National Public Health 
Institute
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INFLUENZA A AND B  YEAR 2004
Infl uenza A broke out exceptionally early, in No-
vember 2003, and peaked in December. The epi-
demic began to subside rapidly in January 2004 and 
was practically over in February.  An equally early 
infl uenza A outbreak was observed in Finland most 
recently in winter 1993/94. In 2003/04 the epidemic 
was caused by a Fujian/411/02 type virus. Toward 
the end of the epidemic, in February 2004 during a 
local outbreak in two garrisons, a Fujian virus vari-
ant was isolated with molecular changes and an-
tigenic characteristics suggesting that this virus 
might cause an epidemic the following winter. The 
return of these Wellington/1/2004 type viruses to 
Finland was confi rmed for the fi rst time in Decem-
ber 2004.
In 2004, only sporadic infl uenza B infections 
were detected. No virus strains were isolated for 
further investigations.
Inß uenza A  epidemics in 19952004
Epidemics were reported every winter during the 
surveillance period. In eight winters the epidemic 
was caused almost solely by an H3N2 subtype virus, 
in one winter by an H1N1 subtype virus (2000/2001). 
In two winters (1995/1996 and 2002/2003) both sub-
types caused an epidemic. In the latter of these 
winters an H1N2 subtype reassortant virus also ap-
peared as epidemic. Mixed epidemics were domi-
nated by the H3N2 subtype virus. The recurrence of 
H3N2 epidemics nearly every year is explained by 
their more rapid variation compared with the H1N1 
viruses. The intensity and time of the outbreaks and 
the target population depend to a great extent on 
the appearance of new virus variants that can break 
through the population’s immunity, and on the ca-
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pability of these variants to replace their predeces-
sors.
The number of cases in the National Infec-
tious Diseases Register provide a reliable picture of 
the timing of the epidemics. The picture of the dif-
ferences in outbreak intensity and target popula-
tion is less accurate. In addition to the epidemiolog-
ical situation, the number of cases is also affected 
by the amount of virological diagnostics. It has in-
creased during the surveillance period, but it has 
focused differently on different age groups in differ-
ent years.
A/H3N2 subtype: Even prior to the surveil-
lance period discussed here, a new variant of the 
H3N2 virus has not always been able to cause an 
extensive epidemic during its fi rst winter. This may 
have been the case also in winters 1994/95–1995/96 
(Figure 1), when the epidemics were caused by the 
same new variant that differed from the reference 
virus (Shangdong/9/93) both genetically and by its 
antigenic characteristics. The fi rst epidemic caused 
by Wuhan/395/95 type viruses in winter 1996/97 
was less intensive than the epidemic of the follow-
ing winter, during which new Sydney/5/97 type 
viruses gradually replaced the Wuhan virus. 
During the subsequent winters, Sydney type viruses 
developed several new branches in the H3N2 virus 
family tree, some of which also found their way 
to Finland. In winter 1998/99 the intensity of the 
epidemic was increased, for example, by viruses of 
the Moscow/10/99 branch and in winter 1999/2000 
by viruses of the Panama/2007/99 branch. Winter 
2000/01, with no H3N2 epidemic in Finland, facili-
tated the return of the Panama branch viruses in 
winter 2001/02. The Fujian/411/02 type H3N2 virus 
of the epidemic season 2002/03 was radically differ-
ent from the Panama virus. Still, there was no major 
epidemic. A more extensive epidemic was observed 
the following winter when the Fujian viruses re-
turned.
The peak of the fi ndings during the H3N2 
epidemics fell usually on January or February. 
Peaks in March 2002 and 2003 and a peak in De-
cember 2003 were exceptions. The late outbreak 
in 2002 was related to the return of the Pana-
ma branch viruses after skipping a year. The late 
outbreak in early spring 2003 was related to the 
spreading of a new Fujian type virus. A new Syd-
Figure 1.  Inß uenza A cases by month 19952004. The subtypes of viruses and the total number of cases are provided by epidemic 
season (September-May).
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ney type virus also spread late as it replaced a Wu-
han type virus from an earlier epidemic period in 
1998. The early outbreak in 2003 may be explained 
by Fujian type viruses remaining in Europe over 
the summer. In June-August 2003 eighteen infl u-
enza A fi ndings were notifi ed to the National Infec-
tious Diseases Register, which is an exceptionally 
high number (only 1–6 cases were notifi ed in other 
summers). Before this Finland had experienced an 
equally early H3N2 epidemic in autumn 1993. That 
time, too, the molecular epidemiology of the virus 
indicated that the virus might have remained in Eu-
rope over the summer.
A/H1N1 and A/H1N2 subtypes: The H1N1 
virus of the mixed epidemic in winter 1995/96 was a 
new Bayern/7/95 type variant of the Singapore/6/86 
type viruses used in vaccines for a long time. Only 
slightly varying, the virus was isolated in Finland 
from one patient in connection with the H3N2 epi-
demic as late as in winter 1997/98. The epidemic 
H1N1 virus of winter 2000/01 was a highly diver-
gent New Caledonia/20/99 type variant that was 
isolated sporadically also in winter 2001/02 and as 
epidemic in winter 2002/03. The H1N2 reassortants 
in winter 2002/03 were also antigenically similar to 
the New Caledonia virus. H1N1 viruses have usual-
ly been described as attacking mainly children and 
young adults. The proportion of patients aged 65 
years or more among the H1N1 fi ndings notifi ed to 
the Infectious Diseases Register in winter 2000/01 
was only 1.9 percent. The proportion in epidemics 
that were caused by H3N2 viruses only and fall en-
tirely within the surveillance period (n=6) was 19.7 
percent (weighted average), being highest in winter 
1999/2000 (32.7%).
Inß uenza B epidemics
Compared with infl uenza A fi ndings, the numbers 
of cases with infl uenza B fi ndings (Figure 2) indicate 
minor outbreaks and sporadic cases, with the ex-
ception of a large epidemic in winter 2002/03. Dur-
ing the surveillance period, antigenic and genetic 
changes have been small with the exception of win-
ter 2002/03, when a Shangdong/7/97 type new vi-
rus caused the epidemic. It belonged to the branch 
of Victoria/2/87 viruses that had disappeared from 
Europe but remained in Asia, having caused a 
previous extensive epidemic in Finland in winter 
1987/88. As expected, in winter 2002/03 a larger 
Figure 2.  Inß uenza B cases by month 19952004 by epidemic season (September-May).
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proportion of the fi ndings were related to children 
under 15 years of age (50%) than in other winters 
of more than a hundred fi ndings (weighted aver-
age 35%). 
Infl uenza B epidemics have usually occurred 
later than the A epidemics. The fi ndings peaked 
twice in May, three times in April and twice in Feb-
ruary. The large epidemic in winter 2002/03 peaked 
as early as January. The main reason for both the 
intensity of the epidemic and its early outbreak was 
probably the weak immunity of the target popula-
tion, which facilitated the spreading of the virus. 
The late outbreak of the small infl uenza B epidem-
ics is probably explained by the minor antigenic 
changes in the virus and the target population’s bet-
ter immunity.
LEGIONELLA
In 2004, there were 16 cases of legionella infection 
altogether. None of the fi ndings were based on cul-
ture. Only four infections were diagnosed by urine 
antigen test, and the rest by serological methods. In 
two cases a diagnostic rise was detected in legionel-
la antibody test, and in ten cases there was a single 
signifi cant titer. Based on physicians’ notifi cations 
and further investigations it became evident that in 
only seven cases the clinical picture was consistent 
with legionellosis, i.e., the patient had clinically or 
radiologically diagnosed pneumonia. All four cases 
with a positive urine antigen test had pneumonia. 
Pneumonia had been diagnosed in only three pa-
tients whose antibody test showed a diagnostic rise 
or who had a single signifi cant titer. All but one of 
the legionellosis cases were male. Their age ranged 
from 42 to 67 years. All patients recovered.
Five of the legionellosis cases in 2004 had 
been exposed during travel, e.g., in a jacuzzi pool or 
at a spa. These were notifi ed to EWGLINET (the Eu-
ropean Surveillance Scheme for Travel Associated 
Legionaires Disease), which collects data on travel-
associated cases of legionellosis. The objective is to 
identify cases related to the same place of accom-
modation in travellers from different countries, so 
that preventive measures can be started as early as 
possible. 
Underdiagnosed legionellosis
In 1995–2004, laboratories notifi ed 5–20 fi ndings a 
year suggesting legionellosis. The fi ndings could be 
based on positive serology, antigen test or culture. 
The number of cases doubled from the period be-
tween 1995 and 2000, with an average of nine cases 
a year, to 2001–2004 when the annual average was 
already 18. Often the source of the sporadic infec-
tions remained unclear. In 1995, Legionella pneu-
mophila serogroup 5, isolated from hot tap water, 
caused an infection in two hospital patients, and the 
problem recurred three years later. In 1999, a new-
born baby was diagnosed with legionellosis, and 
the detected pathogen was of the same strain of le-
gionella that was found in the hot piped water in 
the child’s home.
In 2000–2003, EWGLI detected more than 200 
clusters of legionellosis with the same suspected 
source of infection. Most of these sources were ho-
tels. Nineteen travel-related cases of legionellosis 
were diagnosed in Finland during this period. 
Legionellosis is probably still underdiagnosed 
in Finland. In addition to non-sensitive and non-
specifi c laboratory test methods, the possibility of 
legionellosis is not always recalled when consider-
ing the etiology of pneumonia. A urine antigen test 
in combination with a legionella culture of respira-
tory secretions constitute the best method for diag-
nosing legionellosis.
WHOOPING COUGH  BOOSTER 
VACCINATIONS FOR SIX-YEAR-OLD 
BEGAN IN 2003
The total number of whooping cough cases in 2004 
was higher than ever since the beginning of the 
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surveillance by the National Infectious Diseases 
Register; 1,631 cases (31.3 / 100,000). The previ-
ous peak year was 1999 with 918 cases. When the 
surveillance began in 1995, there were 505 notifi ed 
cases, and the year with least cases during the sur-
veillance period was 2001 with only 315 cases, right 
after the previous epidemic. The proportion of over 
19-year-olds in 2004 was 26 percent. Epidemics fo-
cus particularly on non-vaccinated groups and on 
groups with insuffi cient immunisations, from in-
fants to schoolchildren. The proportion of school 
children is explained by the short duration of hu-
moral immunity: the levels start dropping already 
after fi ve years of age. In 2004, there were 119 cases 
in under 1-year-olds; half of these cases (66) less 
than 3-month-old non-vaccinated infants and 105 
under six months old. In years with a lower total 
number of cases there have been 11–32 cases per 
year in under 1-year-olds. During the previous epi-
demic (1999) there were 83 cases in this age group. 
In 2004, there were 394 cases in the age group 5–9 
years and 461 in the age group 10–14 years. In or-
der to control the epidemic, booster vaccinations 
for 6-year-olds were started in 2003. In the revised 
vaccination programme from the beginning of 
2005, booster vaccinations will be administered to 
4- and 14-year-olds in the future. 
The fi gures in the National Infectious Diseas-
es Register are based on antibody, culture and PCR 
fi ndings. The fi ndings in small children are based 
on conventional culture and the PCR method which 
has been readily available in the whole country dur-
ing the last fi ve years. Throughout the surveillance 
period culture fi ndings constituted less than 5% of 
all fi ndings but 20% of fi ndings in children under 
one year of age. Most cases were based on antibody 
fi ndings; in non-epidemic periods their propor-
tion was more than 90%. In 2004, 29% of the cases 
were detected by PCR testing and 70% by antibody 
testing, and in 2003 the proportions were 10% and 
86%, respectively. The increase in the proportion 
of cases detected by gene multiplication method 
indicates an increased number of infected infants 
and small children during the epidemic. Whooping 
cough is easier to diagnose by clinical picture in in-
fants than in older patients. PCR testing was used 
Figure 3.  Whooping cough (Bordetella pertussis) by month 19952004.
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beside culture also during the previous epidem-
ic, so the diagnostics have not changed much and 
therefore changes in methods do not explain the in-
creased fi ndings among infants. They often contract 
the infection from their school-aged siblings. Thus, 
the revision of the vaccination programme also 
aims at reducing the morbidity of infants (Figure 3).
MYCOPLASMA
Throughout the ten-year period, the Mycoplasma
pneumoniae fi ndings in the register are mainly 
based on serological laboratory tests. Nucleic acid 
and antigen detection assays and/or cultures form 
together a consistently small, practically insignifi -
cant portion of the notifi ed cases in each year of the 
surveillance period. Therefore the years are compa-
rable as regards the detection method. 
Considerable annual variation
Cases have been notifi ed every year during the sur-
veillance period; the highest numbers in 2004 and 
in 2000–2001. In autumn 1995 there were many fi nd-
ings and the epidemic continued in the beginning 
of 1996, but toward the end of the year the number 
of fi ndings decreased, and the years 1997–1999 had 
the least cases in the period. The difference between 
the peak year 2004 and the years with least cases is 
more than sixfold. M. pneumoniae infections occur 
typically as several-months-long epidemics at a few 
years’ intervals, but cases are detected also between 
epidemics. Three distinct epidemics could be iden-
tifi ed during the ten-year surveillance period: In 
1995, a moderate epidemic, fi ve years later a more 
extensive two-peak epidemic that started in 2000 
and continued in 2001, and three years from this 
a very intensive epidemic that started in 2004 and 
still continues in 2005. In addition to large nation-
wide epidemics, mycoplasma causes small local out-
breaks, e.g., in garrisons or classrooms.
In each year of surveillance at least a few cas-
es have been detected every month (Figure 4). In 
years with least cases there has been no distinct 
monthly variation. Epidemics have always begun in 
autumn, in October–November at the latest, contin-
uing over New Year and subsiding in spring. Dur-
ing summer months cases have been sparse. The 
exceptionally intensive epidemic in 2004 got a brisk 
start as early as August and kept intensifying till 
November–December. At that time the fi gures had 
quadrupled from the beginning of the year. 
Infections occur in all age groups, most abun-
dantly among 10–14-year-olds, but many cases are 
also detected in age groups 5–9 and 15–19 years. 
There were few M. pneumoniae cases among small 
children and elderly persons. This is probably at 
least partly explained by fewer paired serum sam-
ples taken from these groups, and also by the lower 
sensitivity of serology in small children.
In 1995, the incidence was slightly higher 
among males than among females; the difference 
was signifi cant only in age groups 15–19 and 20–24 
and can probably be explained by infections among 
conscripts in garrisons. In 1996–2000, the incidence 
was approximately equal among both sexes. After 
this there was a distinct change, and in each year 
from 2001 to 2004 females constituted a signifi cant-
ly or very signifi cantly larger proportion of cases. 
What is the explanation for this? It seems that 25–
49-year-old women had the highest number of “ex-
tra” M. pneumoniae infections. The age distribution 
does not explain this, as the same phenomenon is 
clearly visible among young adults in military servi-
ce age.  
CHLAMYDIA PNEUMONIAE
In 2004, there were 245 laboratory-confi rmed cas-
es of Chlamydia pneumoniae. The number of cases 
has varied during the last 10 years between 188 
and 430, so last year’s level was close to the aver-
age (Figure 4). During the surveillance period the 
incidence was highest in 1996–1997 and 2003. Fin-
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land has had Chlamydia pneumoniae epidemics in 
the late 1950s and in 1977–1978 and 1986–1987. Epi-
demics seem to occur at about 10-year intervals in 
Finland. 
In 2004, more Chlamydia pneumoniae infec-
tions were notifi ed for males than females in the 
age group under 30 years, while in the age group 
30–45 years the clear majority of cases was notifi ed 
among females. This is in line with the view that 
schoolchildren transmit the disease to their mothers 
and that the incidence of Chlamydia pneumoniae is 
higher among conscripts (most of them male) in the 
military, where it also is diagnosed more actively. 
In older age groups the differences between males 
and females are small. 
In 2003, the incidence was highest in the prov-
inces of Western Finland and Lapland, while in 
1996–1997 Oulu, Lapland and Åland were the prov-
inces with the highest incidence. In the province 
of Southern Finland the annual incidence does not 
vary nearly as much as in the less densely populat-
ed regions. Differences in diagnostic activity may 
partly explain the differences.
The diagnostics of Chlamydia pneumoniae in-
fections are mainly based on serology. A few years 
ago most laboratories started using commercial 
EIA tests instead of the microimmunofl uorescence 
method. The high number of cases in 2003 may 
partly be explained by the introduction of new, pos-
sibly more sensitive EIA methods, but the return of 
the number back to average level in 2004 does not 
support this theory.
RSV  MOST COMMON IN BABIES 
AND SMALL CHILDREN
Respiratory syncytial virus (RSV) causes serious 
respiratory infections particularly in babies and 
small children. However, it is also a signifi cant path-
ogen in adults and elderly people, even though only 
6.5 percent of the nearly 15,000 RSV fi ndings noti-
fi ed in 1995–2004 were diagnosed in over fi ve-year-
old patients. The proportion of over 60-year-olds 
was 1.5 percent (Figure 5).
RSV has caused epidemics every year dur-
ing the surveillance period, and it has been detect-
ed in the population continuously. RSV outbreaks 
follow the same pattern from year to year: in the 
Figure 4.  Chlamydia pneumoniae and Mycoplasma pneumoniae by month 19952004.
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spring of an odd year there is a peak that subsides 
by summer. In autumn the infections begin to in-
crease again, and a more intensive outbreak occurs 
around New Year. In the winter of the even year 
the epidemic is still intense, but only a few cases 
are detected in summer and the incidence does not 
increase signifi cantly before New Year. A new epi-
demic occurs in the spring of the next, odd year. 
RSV causes epidemics globally every year, but 
the regular pattern described above has been de-
tected only in the Nordic countries. The rather mild 
spring epidemic of odd years always subsides by 
summer. The immunological characteristics of the 
relatively sparse population may be one reason for 
this exceptional recurrence pattern. There are two 
types of RS virus, RSV A and RSV B, both with sub-
types. In Finland one of the main types, RSV A or 
RSV B, dominates for a couple of years at a time, 
after which the roles are reversed.  A stronger im-
munity develops only after a child has had both 
types of RSV infections, but even then the immunity 
is not long-lasting and RS viruses cause recurrent 
infections. Boys form the majority of cases diag-
nosed in under ten-year-olds (55–60 percent).
The fi rst RSV vaccines will probably be intro-
duced in a few years. Old people may be the fi rst 
group to receive these vaccines, and therefore more 
information on the frequency of RSV infections and 
their clinical signifi cance is needed from all age 
groups in the Finnish population.
ADENOVIRUS  RARE IN ADULTS?
Adenoviruses cause respiratory and intestinal infec-
tions. They are common pathogens in infants and 
small children but less common in adults. Intense 
adenovirus epidemics occur often in the Defence 
Forces.
Respiratory adenovirus infections were diag-
nosed by antigen detection or virus culture from 
aspirated mucus (sputum or bronchoscopy sample) 
and also serologically. The number of cases 
was highest in the age group of under four-year-
olds (average 312 cases/year) and next highest in 
age groups 15–19 (average 79 cases/year) and 20–24 
(average 43 cases/year), i.e., the normal military 
Figure 5.  RSV (Respiratory syncytial virus) by month 19952004.
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service age. Adenovirus epidemics occurred in 
garrisons after the arrival of new recruits. 
In other age groups there were fewer cases and 
they occurred evenly around the year (Figure 6).
PARAINFLUENZA  ESPECIALLY 
IN CHILDREN
Parainfl uenza viruses are gathered under the 
same heading in the National Infectious Disea-
ses Register, even though laboratories often sepa-
rate parainfl uenza viruses 1, 2 and 3. During the 
ten-year period parainfl uenza virus infections were 
notifi ed particularly in infants, small children and 
to some extent in small schoolchildren, more in 
boys than girls. Very few adults were notifi ed with 
these infections.
In 1996, 2001 and 2004 the highest peaks 
occurred in March–May, and in 1998 and 2002 
in November–December. 
Figure 6.  Adenovirus by month 19952004.
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SALMONELLA
In 2004, there were 2,248 notifi ed salmonella cases 
of other serotypes than Salmonella Typhi or 
S. Paratyphi, which was approximately similar to 
the level in 2003. Of these cases 46% were diag-
nosed in males (1,025) and 54% in females (1,223). 
The annual incidence in the whole country was 
43 cases per 100,000 population. The incidence 
was highest in the hospital districts of Kainuu 
(75/100,000) and Helsinki and Uusimaa (57/100,000) 
and lowest in the hospital districts of Pohjois-
Pohjanmaa (27/100,000), Päijät-Häme (27/100 000) 
and Vaasa (28/100,000). The incidence was high-
est (more than 50/100,000)  in the age group 20–54 
years and lowest (10/ 100,000) in the age group over 
75 years.
The most common Salmonella serotypes were 
Enteritidis (869 cases), Typhimurium (327 cases), 
Stanley (115 cases), Virchow (82 cases) and New-
port (61 cases).
Of the notifi ed salmonella infections, 320 
(14%) were acquired in Finland and 1,795 (80%) 
abroad. No country of acquisition was specifi ed 
for 139 cases (6%). S. Typhimurium serotype caused 
125 (39%) of the domestic cases; the most com-
mon phage type was FT 1 (30%), an endemic phage 
type in Finland. The second most common sero-
type among the domestic cases was S. Enteritidis 
(87 cases, 25%). The incidence of domestic salmo-
nella cases was 6.1 per 100,000 population; the in-
cidence was highest among under fi ve-year-olds 
(15.5/100,000). In Kainuu hospital district the inci-
dence of domestic cases was 43/100,000, which 
was considerably higher than in the other hospital 
districts. 
The incidence of salmonella cases acquired 
abroad was 34/100,000 population. The incidence 
INTESTINAL INFECTIONS
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was highest (65/100,000) in the age group 25–29 
years and in the HUS hospital district (48/100,000). 
The S. Enteritidis serotype caused 738 (41%) of the 
infections contracted abroad. The next most com-
mon serotypes acquired abroad were Typhimurium 
(177 cases), Stanley (104 cases), Virchow (74 cases) 
and Newport (52 cases). The most common coun-
tries of acquisition were Thailand, Spain, Bulgaria, 
Greece and Egypt, each with more than a hundred 
notifi ed cases. 
Serotype S. Typhi caused six cases, S. Para-
typhi A four, S. Paratyphi B four, and S. Paratyphi 
C one case. All these infections were contracted 
abroad, most of them in the Indian peninsula.
Considerable improvement in 10 years
The annual number of salmonella cases in Finland 
has decreased clearly during the ten-year period. In 
the latter half of the 1990s there were still approx-
imately 3,000 cases a year, while in the last three 
years the number has been clearly below 2,500. This 
development is seen both in domestic cases and in 
cases contracted abroad. (Table 1). Until 2001 Spain 
was the most common country of acquisition, but 
after that Thailand has clearly topped the list (358–
406 cases per year). The number of infections con-
tracted in Bulgaria, Egypt and Brazil has increased 
in recent years, whereas the number of infections 
acquired in Estonia, Tunisia and Morocco has de-
creased.
Outbreaks in 2004
In January some guests attending a wedding recep-
tion in Lapinlahti contracted salmonellosis. S. Ty-
phimurium var. Copenhagen, FT 104, multiresistant 
strain, was detected in 16 guests by stool culture. 
The vehicle could not be identifi ed in the question-
naire study conducted. One person with gastroin-
testinal symptoms, under treatment with antibiot-
ics, had participated in the preparation of the meal. 
No salmonella was detected in this patient’s stool 
culture taken after the course of antibiotics.
In February nineteen out of approximate-
ly twenty people attending a family gathering in 
Suomussalmi contracted S. Agona infection; the 
strain was susceptible to antibiotics. The source 
of infection remained uncertain; the person who 
had prepared the food was salmonella positive but 
symptomless. 
In February–March four children at a day-
care centre in Vantaa were diagnosed with an infec-
tion caused by a multiresistant S. Typhimurium FT 
104 strain. Hand hygiene was enhanced at the day-
care centre to get the outbreak under control.
In August some guests attending a wedding 
reception in Kuopio contracted salmonella infec-
tion. More than 20 persons had symptoms, and an-
tibiotic-susceptible S. Enteridis of an extremely rare 
phage type FT 13var was found in the stool cultures 
of 16 guests. The strains were also identical in gen-
otyping, and their DNA profi le was rare. The ques-
tionnaire study conducted indicated that the vehicle 
was pasta salad. 
In August–September fi ve people were diag-
nosed with S. Enteritidis FT 8 infection, probably 
acquired at a football camp in Slovakia. 
In September four people in Oulu contract-
ed S. Enteritidis FT4 infection. The susceptibility of 
the strain to ciprofl oxacin was reduced. Imported 
chicken was suspected as the source of infection.
In December a family’s pet turtle transmitted 
S. Braenderup infection to six persons.   
Resistance situation
In the 2000s the Laboratory for Enteric Patho-
gens has subjected all salmonellas to epidemiologi-
cal susceptibility testing involving 12 antimicro-
bials (ampicillin, chloramphenicol, streptomycin, 
sulphonamide, tetracycline, trimethoprim, cipro-
fl oxacin, gentamycin, nalidixic acid, cefotaxime, me-
cillinam, imipenem). In 2004, 13 percent of domes-
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
tic and 10 percent of strains acquired abroad were 
multiresistant (resistant to at least 4 antimicrobi-
als). In 2001–2002, the respective percentages were 
11 and 10. Nearly all domestic multiresistant strains 
were of type Typhimurium, FT 104. It is somewhat 
alarming that domestic infections caused by this 
invasive salmonella type have increased continu-
ously (3% of all domestic infections in 2002, 9 % in 
2003, 10 % in 2004). Particularly Thailand and Egypt 
can be regarded as the “storage” for multiresistant 
strains. Among them multiresistance was often as-
sociated only with certain serotypes, like Stanley, 
Panama and Rissen serotypes in Thailand and New-
port, Virchow and Kentucky serotypes in Egypt. 
The resistance of the last-mentioned serotype was 
particularly striking: more than 30% of strains were 
fully resistant (MIC ≥ 4 mg/l) to ciprofl oxacin. The 
resistance to nalidixic acid can be used to predict 
reduced susceptibility to ciprofl oxacin. In 2004, 11 
percent of domestic strains (9% in 2001–2002) and 
24 percent of strains acquired abroad (24% also in 
2001–2002) were resistant to nalidixic acid. 
CAMPYLOBACTER  INCIDENCE BEGAN 
TO RISE AGAIN
The declining trend of campylobacter cases ceased 
in 2004, and the number of notifi ed cases was ap-
proximately 13% higher than the preceding year. 
Ninety-fi ve percent of the notifi ed cases were 
caused by Campylobacter jejuni and fi ve percent by 
Campylobacter coli. Fifty-four percent of the cases 
were male. The incidence in the entire population 
was 69/100,000. The majority of notifi ed cases (53%) 
was detected in the age group 20–44 years, with an 
incidence of approximately 100/100,000 population. 
Since the beginning of 2004, information 
has been collected on travel preceding campylo-
bacter infections making it possible to distinguish 
infections acquired in Finland from those acquired 
abroad. The information on the possible place of ac-
quisition was obtained from 2,150 patients (61%). 
Sixty-eight percent of these had been abroad just 
prior to becoming ill. 
The number of notifi ed campylobacter cases 
exceeded the number of salmonella cases for the 
Figure 7.  Salmonella and Campylobacter cases by month 19952004.
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fi rst time in 1998, and since then campylobacter has 
been the most common bacterial cause of intestinal 
infections in Finland (Figure 7). Since 1999, more 
than 3,000 cases have been notifi ed each year. The 
seasonal variation typical for campylobacter infec-
tions is visible in the fi gures of 1995–2004. Every 
year the peak month of incidence has been July. 
Similar seasonal variation has been detected in oth-
er Nordic countries as well. 
Based on the investigations conducted by the 
Laboratory for Enteric Pathogens at the National 
Public Health Institute, the majority (68%) of infec-
tions detected in July–August were acquired do-
mestically. 
In the age distribution of campylobacter 
cases there is a distinct peak in the age group of 
young adults, which probably refl ects the popular-
ity of travelling among them. The number of cas-
es increased in 1995–2001 in the age group 15–64. 
Among under 15-year-olds and over 65-year-olds 
the incidence has remained approximately at the 
same level for the past ten years. 
The incidence of campylobacter infections 
in 1995–2004 was highest in the hospital district 
of Helsinki and Uusimaa, where the incidence per 
100,000 population has varied approximately from 
100 to 150. The year 1998 was an exception, as the 
highest individual regional incidence during the ten 
years of surveillance was detected in the hospital 
district of Ahvenanmaa (173/100,000). Last year the 
incidence in the Ahvenanmaa hospital district was 
the lowest (22/100,000) in all of Finland (Figure 8).
YERSINIA
In 2004, there were 681 notifi ed cases of yersinia. 
Eighty-one percent of these were Yersinia enteroco-
litica infections and 19 percent were Yersinia pseu-
dotuberculosis infections. 
The incidence of the different yersinia species 
varied between age groups. The highest number 
of Y. enterocolitica infections was detected in over 
40-year-olds, while the incidence of Y. pseudotuber-
culosis was highest among those under 15 years of 
age . 
The highest incidences of Y. pseudotuber-
culosis infections were detected in the hospital
districts of Keski-Pohjanmaa and Pohjois-Pohjan-
maa (23/100,000 and 10/100,000, respectively). The 
hospital districts with the highest incidence of Y. 
enterocolitica infections were Kainuu (19/100,000), 
Ahvenanmaa (19/100,000) and Helsinki and Uusi-
maa (18/100,000). 
The number of yersinia cases notifi ed to the 
register was 923 in 1995 and 852 in 1996. After that 
1030 cases / 100,000 inhabitants
3150 cases / 100,000 inhabitants
5170 cases / 100,000 inhabitants
more than 70 cases / 100,000 inhabitants
Figure 8.  Incidence of Campylobacter cases by hospital 
district in 2004.
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approximately 600–700 cases have been notifi ed 
each year (Figure 9). Annually there have been 400–
600 notifi ed cases of Y. enterocolitica and 30–180 
of Y. pseudotuberculosis. The incidence of yersini-
ae has remained at the same level for the past eight 
years.
Yersinia outbreaks  outbreak investigations
conducted in many regions
In 2004, there was an outbreak caused by the O:1 
serotype of Y. pseudotuberculosis among school-
children in Haapavesi, and it manifested itself also 
as a wide-spread regional outbreak in the hospital 
districts of Vaasa, Keski-Pohjanmaa and Pohjois-Po-
hjanmaa. The investigation of the school outbreak 
and a population-based case-control study again 
identifi ed domestic carrots as the source of infec-
tion. The farm where the carrots were grown was 
not the same one where the source of the previous 
year’s epidemic was traced to. Two different geno-
types were detected in the patient strains. One of 
them was identical to the genotype found in the 
strains isolated from the traced farm’s carrots and 
the shrews caught in the carrot fi eld. 
Y. enterocolitica infections have occurred 
mainly as sporadic cases in different parts of the 
country, but some smaller outbreaks have also been 
detected. No association has been established be-
tween the cases and any particular food(s) so far. It 
is probable that in regions with high incidence, epi-
demics manifest themselves as sporadic cases, and 
therefore it is hard to fi nd a connecting factor.  
SHIGELLA  USUALLY CONTRACTED 
ABROAD 
The incidence of shigellosis in 2004 was 2.1/100,000 
population. Altogether 109 cases were notifi ed, and 
47 of the patients were male. The highest incidence 
(5.3/100,000) was detected in the age group 25–39 
years. No cases were notifi ed among those aged 75 
years or more. More than half of the cases (57) were 
notifi ed from the hospital district of Helsinki and 
Uusimaa, where the incidence was also higher than 
in the other hospital districts (4.0/100,000). More 
than 90 percent of the infections were contracted 
abroad. The most common country of acquisition 
was Egypt, like many times earlier. The number of 
cases acquired in Brazil (11) was higher than be-
Figure 9.  Yersinia enterocolitica and Y.pseudotuberculosis cases 19952004. 
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fore. More than half of the infections acquired in 
India, China and Sri Lanka were caused by strains 
with reduced susceptibility to ciprofl oxacin. Seven-
ty-fi ve percent of the cases were caused by Shigella 
sonnei and 16 percent by Shigella fl exneri. Only one 
Shigella dysenteriae infection was detected. 
With the exception of year 2001, there have 
been 70–110 cases of shigella notifi ed in Finland 
each year. In 2001, the number of cases was as high 
as 223, which is partly explained by a restaurant 
outbreak in Kymenlaakso. That year there were also 
exceptionally many infections contracted in Egypt, 
which was mainly due to increased tourism to that 
country (Table 2). 
 The majority of infections have been acquired 
abroad, and the number of domestic cases has nor-
mally been fewer than 10. Egypt has been the most 
common country of origin throughout the surveil-
lance period, followed by India and Turkey. In the 
entire period from 1995 to 2004, Shigella sonnei has 
caused 72 percent and Shigella fl exneri 19 percent 
of all cases.
EHEC  FEWER CASES THAN EVER IN 2004
In 2004, ten microbiologically confi rmed cases of 
Enterohemorrhagic Escherichia coli (EHEC) were 
notifi ed (0.2/100,000/year), fi ve of them males. The 
Figure 10.  EHEC Þ ndings 19962004
  1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Infections acquired 
in Finland 5 10 9 8 4 8 50 6 3 6
Infections acquired 
abroad 67 85 86 73 63 61 170 76 60 98
 Egypt 3 8 9 1 11 15 53 18 18 37
 India 16 14 21 8 2 10 10 10 8 13
 Turkey 8 16 3 20 6 2 21 10 1 5
 others 40 47 53 44 44 34 86 38 33 43
Place of acquisition 
unknown 1 12 9 7 4 6 3 5 3 5
Total 73 107 104 88 71 75 223 87 66 109
Table 2.  Shigella infections acquired domestically and abroad 19952004.
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total number of cases was smaller than ever since 
1996 (Figure 10), when EHEC was added to the list 
of category A notifi able communicable diseases.
 All cases were under 40 years old, among 
them two under fi ve-year-olds. None of them devel-
oped haemolytic uraemic syndrome (HUS). 
Six of the infections were contracted in Fin-
land and four abroad. One of the domestic cas-
es was a child under fi ve. Four of the cases were 
caused by the EHEC O157:H7 serotype, three of 
them acquired abroad. Six cases were caused by 
EHEC non-O157:H7 serogroup, fi ve of them of 
domestic origin. With the exception of two cases 
caused by non-O157 serogroup in the members of 
the same family, all domestic EHEC non-O157 cases 
were caused by different serogroups. All cases who 
had acquired EHEC non-O157 infection in Finland 
either lived on a cattle farm or were otherwise in 
close contact with a cattle farm. 
The annual incidence of EHEC cases in 
Finland has been internationally very low (0.3–
0.9/100,000), and the trend has still been downward 
in recent years. In 1998, the O157 serogroup consti-
tuted more than half of all cases, but after that the 
proportion of non-O157 strains has become consid-
erable (Fig 10). HUS was diagnosed in 16 patients 
(11 O157 cases and 5 non-O157 cases). Twelve of 
these were under fi ve-year-olds, and twelve were 
girls. In 1998, two small EHEC O157:H7 clusters 
were detected. One of them probably resulted from 
infection being transmitted from person to person, 
and the other one was possibly due to infections 
transmitted by hamburgers. 
LISTERIA  CASE FATALITY 
RATE 23 PERCENT 
The annual incidence of listeriosis in 2004 was sev-
en cases per million population. 
  
A total of thirty-fi ve cases were notifi ed. Fifty-
one percent of the patients were male and 71 per-
cent were 65 years of age or older (Figure 11).There 
were 25 cases with fi ndings from blood and three 
from CSF, and six with fi ndings from other aspirat-
ed samples. Six cases had a malignant haematologi-
cal disease as a predisposing factor, and one case 
had other cancer. Only two cases had no predispos-
ing underlying condition. Eight of the cases (23%) 
died, three of them within a week after the positive 
listeria fi nding, and seven within a month.  One of 
the cases was pregnant. No infections were detect-
ed in neonates. Listeriosis was detected in nearly all 
hospital districts with the number of cases ranging 
from zero to fi ve.
Figure 11.  Incidence of listeriosis cases 19952004.
I N F E C T I O U S  D I S E A S E S  I N  F I N L A N D  1 9 9 5  2 0 0 4
25
Serotype 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
 n=21 n=21 n=47 n=43 n=45 n=19 n=27 n=20 n=40 n=32
1/2 15 15 27 19 25 16  20 13 36 23
3a 1 0 4 19 10 0 0 0 0 0
4b 5 6 16 5 10 3 7 7 4 9
Serotype 1/2 caused 73 percent of the cases, 
and serotype 4b caused 27 percent. Seven of the 
serotype 4b listeria strains were of the same liste-
ria genotype. This genotype could not be traced to 
any individual food product. It caused infections in 
many hospital districts around Finland (Table 3).
The National Food Agency, the National Vet-
erinary and Food Research Institute and the Na-
tional Public Health Institute informed the public 
three times in 2000 and once in spring 2003 that 
vacuum-packed rawpickled or cold-smoked fi sh 
may be contaminated by Listeria monocytogenes, 
which can cause illness in risk groups. In 2004, at 
least three cases were diagnosed with a listeria in-
fection caused by a genotype isolated earlier from 
vacuum-packed smoked and rawpickled fi sh. There 
were three similar cases of listeriosis in 2002 and 
eleven in 2003. In 1997–1999, serotype 3a caused lis-
teria infections that were for the most part related 
to an epidemic transmitted by butter.
NOROVIRUSES  MOST INFECTIOUS 
IN WINTER
In 2004, there were 125 notifi ed cases of norovirus, 
70 of them females. More cases were notifi ed during 
the winter months than during the rest of the year. 
The incidence 2.4/100,000 was clearly lower than in 
the two preceding years. The highest incidence was 
detected among under fi ve-year-olds (6.0/100,000), 
but cases were notifi ed from all age groups. The in-
cidence was highest in the hospital districts of Vars-
inais-Suomi and Helsinki and Uusimaa, which prob-
ably indicates that these districts employ a more 
active diagnostic practice. December was clearly the 
peak month for notifi ed cases (26).
The diagnostics of norovirus infections are 
based either on a PCR test or on electron micros-
copy, which are less readily available than, for ex-
ample, a stool culture. Therefore the notifi ed no-
rovirus cases indicate poorly the actual number of 
infections. From 1998 to 2004, 125–836 norovirus 
cases per year were notifi ed to the National Infec-
tious Diseases Register. The incidence was highest 
in 2002. A new norovirus genotype appeared then, 
causing exceptionally abundant infections around 
the world. At the end of last year a new norovirus 
type was detected in Finland and elsewhere in Eu-
rope. The increased incidence toward the end of the 
year is probably related to the appearance of this 
new type.
ROTAVIRUS
In 2004, the incidence of rotavirus was 25/100,000; 
there were 1,322 notifi ed cases, 712 male and 
610 female. Rotavirus infections were most com-
mon in January–June. The incidence was clear-
ly highest among children under fi ve years of age 
(418/100,000); they constituted 90 percent of all cas-
es. Cases were notifi ed from all hospital districts ex-
cept Ahvenanmaa. 
In 1995–2004, the annual incidence of rota-
virus has been 20–42/100,000 population. The in-
cidence begins to rise around New Year, peaks in 
March–May, drops during summer months and is at 
Table 3.  Serotype distribution of Listeria monocytogenes strains 19952004.
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its lowest in autumn. Rotavirus patients are typical-
ly small children; 6–24 months is the age group with 
the highest incidence. 
FOOD- AND WATER-BORNE OUTBREAKS
NotiÞ cation system for suspected outbreaks
implemented in 1997
Since 1997, Finland has employed a special notifi -
cation system for suspected food- and water-borne 
outbreaks. Its purpose is to serve as an early and 
fast channel of communication when local health or 
environmental authorities have detected gastroin-
testinal illness suspected to be caused by food or 
potable water. Since 1997, the number of outbreak 
investigation reports to the National Food Agency 
has approximately tripled from the preceding years.
Whenever necessary, the National Public 
Health Institute (KTL) assists the municipal authori-
ties in investigating an outbreak, or it may also as-
sume the main responsibility particularly when the 
number of ill is high or an epidemic occurs in sever-
al municipalities or hospital districts. New food ve-
hicles have been identifi ed in KTL’s outbreak inves-
tigations in recent years, such as butter in a listeria 
outbreak and iceberg lettuce in a Yersinia pseudo-
tuberculosis outbreak. KTL has also investigated 
the modes of transmission in other than food- and 
water-borne epidemics. Examples of these include 
a tularemia outbreak in 2000 and a Pogosta disease 
outbreak in 2002.
In 2004, KTL received 67 notifi cations of sus-
pected outbreaks. A Yersinia pseudotuberculosis 
outbreak in Pohjanmaa in March led to detailed in-
vestigations; in addition to local authorities the in-
vestigators included KTL, the National Veterinary 
and the Food Research Institute of Finland (EELA), 
the Finnish Forest Research Institute and the Na-
tional Food Agency. Epidemiological and micro-
biological investigations showed that the infections 
had been transmitted by carrots. The fl ooding due 
to the summer’s heavy rainfall contaminated water 
at many municipal water works. Major water-borne 
epidemics were, however, avoided.
Since 2001, applying uniform criteria, a work-
ing group formed by KTL, the National Food Agen-
cy and the National Veterinary and Food Research 
Institute of Finland has evaluated the strength of 
the evidence on outbreaks reported as food- or wa-
ter-borne. The association to food or potable wa-
ter is graded as strong, probable, possible, weak 
or none, the last-mentioned indicating that there 
is no evidence on the epidemic being food- or wa-
ter-borne. In 2001–2003, there were 275 notifi ed 
outbreaks, and 129 of them were assessed to be 
transmitted by food or potable water. Food-borne 
outbreaks constituted 110 of these, and 19 out-
breaks were water-borne. Most of the outbreaks 
that were assessed to have some other way of 
transmission were norovirus epidemics transmitted 
from person to person.
The most usual microbial causes of food-
borne epidemics were norovirus, salmonella, 
Clostridium perfringens and yersiniae (Table 4). The 
most common food vehicles included meat, veg-
etable and fi sh products. In more than a third of 
the outbreaks the source was food served in a res-
taurant. In nineteen outbreaks the infections were 
Cause n %
 Unknown 38 34,5
 Norovirus 35 31,8
 Salmonella 8 7,3
 Biogenic amine 6 5,5
 Cl. perfringens 5 4,5
 Yersinias 5 4,5
 Staph. aureus 4 3,6
 Bacillus cereus 4 3,6
 Campylobacter jejuni 2 1,8
 Other bacterium 2 1,8
 Chemical substance 1 0,9
Total 110 100
Table 4.  Aetiology of food-borne epidemics in Finland
20012003.
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probably transmitted by an infected employee; in 
most of these cases the employee had a norovirus 
infection. Norovirus and Campylobacter jejuni were 
the most common microbes causing water-borne 
epidemics.
Salmonella  18 outbreaks per year
During the current outbreak notifying system 1–8 
food-borne salmonella outbreaks have been ob-
served each year in Finland. Around New Year 
1997–1998 about a hundred persons attending two 
funerals were infected by Salmonella Newport.  
Ham was identifi ed as the source of infection in the 
questionnaire study conducted. At the same time in-
fections caused by the same salmonella strain were 
detected in England. 
In May 1999, more than 70 people in Southern 
Finland contracted S. Typhimurium FT 193. Alfalfa 
sprouts were identifi ed as the source of infection in 
a case-control study. 
In August 1999, cheese made from milk 
bought directly from a farm caused an outbreak 
with more than 100 persons becoming ill in Varsi-
nais-Suomi.
Campylobacter  the cause of many water-borne 
epidemics
Food poisonings caused by Campylobacter have 
occurred as sporadic cases, and outbreaks have 
been small (3–15 ill persons). The vehicles or sus-
pected vehicles have included turkey, milk bought 
directly from a farm, chicken prepared with sour 
cream, fresh strawberries and chicken fi llets. 
Instead, campylobacter has caused many wa-
ter-borne outbreaks in the past ten years. Extensive 
outbreaks associated with municipal water intake 
plants occurred in Haukiputaa in 1998, Asikkala in 
2000 and Vihti and Kangaslampi in 2001. Several 
thousand persons in total became ill in these out-
breaks. In 2001, an outbreak transmitted by natural 
water occurred in Lapland, with all 17 members in 
a group of hikers becoming ill after drinking creek 
water. In 2003, there was a small family outbreak 
in Lapland, when spring water had been used for 
drinking in a rental cottage.
Shigella  many cases from Egypt in 2001
In 2001, there were 222 notifi ed cases of shigella, 
which is an exceptionally high fi gure. This is partly 
explained by a Shigella sonnei outbreak in Kymen-
laakso in August–September, with more than 40 
persons falling ill. The cases had dined at the same 
café serving home-made food. One of the employ-
ees of the cafe had shigella infection, probably ac-
quired in Tallinn. 
EHEC  outbreak caused by kebab
In 2001, a small EHEC O157:H7 outbreak occurred 
in Finland, and foreign kebab meat was identifi ed 
as the source of infection. 
Listeria  outbreak caused by butter
In 1998–1999, Listeria monocytogenes serotype 3a 
caused an outbreak transmitted by butter, with 25 
people becoming ill. The listeria strains isolated 
from the patients and the butter produced by one 
manufacturing plant had also similar genotypes.  
Yersinia  outbreaks caused by school food
In the past ten years, Y. pseudotuberculosis has 
caused recurring outbreaks of food poisoning. 
Many of them have been associated with eating at 
school. In 1997–1999, the most common cause of 
outbreaks was Y. pseudotuberculosis serotype O:3. 
Serotypes O:3 and O:1 were identifi ed in the 2001 
epidemic.
The fi rst such outbreak was detected in Au-
gust 1997 in the Pirkanmaa hospital district. In Au-
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gust 1998, another outbreak in a school occurred in 
the same hospital district. Vegetables were suspect-
ed as the vehicle already then.
A wide-spread regional outbreak occurred 
also in Southern Finland in autumn 1998. In a popu-
lation-based case-control study, domestic iceberg 
lettuce was identifi ed as the source of infection. A 
regional outbreak occurred also in 1999.
Several small clusters caused by serotypes 
O:1 and O:3 occurred simultaneously in the Kainuu, 
Mikkeli and Pori regions in 2001. 
In the following autumn, 2002, an outbreak 
caused by Y. pseudotuberculosis serotype O:3 oc-
curred  in the Kymenlaakso region. 
In spring 2003, Y. pseudotuberculosis serotype 
O:1 caused an extensive food poisoning outbreak 
among schoolchildren in Kymenlaakso. The number 
of ill was estimated to be about 800. The investiga-
tion showed that domestic carrots were the source 
of infection. For the fi rst time a strain with the same 
serotype and genotype was isolated both from the 
cases and the carrots traced to the farm of origin.
A the end of 2003, Y. enterocolitica, sero-
type O:3, caused an outbreak in Kymenlaakso, with 
more than 20 persons contracting severe abdomi-
nal symptoms and three persons having an unnec-
essary appendectomy. In December 2004, serotype 
O:3 caused a cluster of infections at a ski centre. 
Norovirus  the cause of outbreaks transmitted 
by domestic water
Norovirus has caused many extensive outbreaks 
transmitted by potable water in Finland. Norovirus 
has also been transmitted by food. At the end of the 
1990s imported frozen berries were identifi ed as the 
source of infection in many outbreaks. In the most 
extensive outbreak in 1998 about 500 persons be-
came ill.
In 1998, 1,700–3,000 people in Heinävesi were 
estimated to have fallen ill due to water-borne noro-
virus infection. 
In 2000, in Nurmes it was estimated that up to 
5,000 persons fell ill.
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HEPATITIS A 
In 2004, there were 42 notifi ed cases of hepatitis 
A, 19 males and 23 females. The annual incidence 
was 0.8/100,000 population, which was considera-
bly lower than in the previous year. There were pa-
tients in all age groups, but the incidence was high-
est among 30–34-year-olds. Ten hospital districts 
had no detected cases. Eleven infections had been 
acquired in Finland, 20 abroad, and 11 were of un-
known origin. 
The incidence of hepatitis A has varied con-
siderably in Finland. During the outbreak among 
IDUs (injecting drug users) in the capital region in 
1994–1995 the incidence rose markedly; more than 
400 cases were registered in 1994. After this the in-
cidence decreased gradually, and in 1999–2001 ap-
proximately 50 cases per year were notifi ed, about 
half of which were acquired abroad (Table 5). Rus-
sia (62 cases), Estonia (42 cases) and Turkey (26 
cases) have been the most common countries of ac-
quisition other than Finland among the registered 
cases in the past ten years. In association with the 
outbreak among IDUs in 2002–2003, the incidence 
increased nearly tenfold from the previous years. In 
2002, an extensive vaccination campaign was car-
ried out in the capital region among IDUs, and this 
seemed to control effectively the epidemic. In 2003, 
smaller outbreaks occurred among IDUs in other 
hospital districts. 
As outbreaks among IDUs have become a re-
current phenomenon, hepatitis A vaccination for 
this risk group was included in the general vaccina-
tion programme in the beginning of 2005.
HEPATITIDES
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Table 5.  Hepatitis A cases 19952004.
Year Domestic Origin Foreign origin Unknown origin Total
1995 81 34 49 164
1996 90 40 56 186
1997 73 48 48 169
1998 58 36 26 120
1999 17 19 12 48
2000 18 24 9 51
2001 25 20 6 51
2002 293 37 63 393
2003 154 16 72 242
2004 9 20 13 42
HEPATITIS B
Fewer acute hepatitis B cases among injecting 
drug users
The number of acute hepatitis B cases notifi ed to 
the National Infectious Diseases Register has clear-
ly decreased during the past 10 years (Table 6). The 
most rapid decrease has occurred in cases trans-
mitted by injecting drugs. Early in the surveillance 
period distinct smaller outbreaks occurred among 
drug users in different parts of the country, for ex-
ample in Kuopio and Turku. 
Probable reasons for the decreased number of 
cases include both the extensive needle and syringe 
exchange programme and the hepatitis B vaccina-
tions offered to drug users especially at the needle/
syringe exchange centres. Further proof of the effi -
ciency of exchange programme is the fact that in re-
cent years hepatitis B cases associated with the use 
of injecting drugs have occurred mainly in places 
without any needle/syringe exchange centres, like 
Vaasa. The decreased number of hepatitis C infec-
tions also indicates the importance of clean injec-
tion equipment in hepatitis prevention (Figure 12).
 1995  1996  1997  1998  1999
 Acute HBV HCV Acute HBV HCV Acute HBV HCV Acute HBV HCV Acute HBV HCV
Injecting drugs 15 .. 57 .. 56 .. 76 1 019 106 986
Sex 21 .. 45 .. 58 .. 44 54 36 34
Perinatal 0 .. 1 .. 1 .. 1 4 0 10
Blood products 22 .. 69 .. 52 .. 4 24 1 22
other 3 .. 20 .. 11 .. 4 24 9 40
unknown 51 .. 98 .. 137 .. 117 678 103 660
Total 112 1 358 290 1 778 316 1 904 246 1 803 256 1 753
 2000  2001  2002  2003  2004
 Acute HBV HCV Acute HBV HCV Acute HBV HCV Acute HBV HCV Acute HBV HCV
Injecting drugs 82 920 28 814 43 693 18 619 8 578
Sex 39 39 41 41 37 46 19 45 15 57
Perinatal 1 6 0 3 1 3 1 2 0 9
Blood products 1 24 1 18 1 18 0 22 2 18
other 8 30 6 31 2 28 1 33 4 30
unknown 108 720 51 583 92 582 67 543 28 546
Total  239 1 739 127 1 491 176 1 371 106 1 265 57 1 238
Table 6.  Acute hepatitis B cases and all hepatitis C cases by mode of transmission 19952004.
Between 19952004 four HBV cases have been notiÞ ed to have been transmitted by Finnish blood products. Since 2000 no cases of HCV transmitted by 
Finnish blood products have been notiÞ ed. The surveillance for the mechanism of transmission for HCV was started in 1998.
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Mode of transmission is not always notiÞ ed 
The mode of transmission has been notifi ed for 
only about every third hepatitis B case. While in 
1998 two thirds of the acute infections with mode of 
transmission notifi ed were still related to drug use, 
these cases constituted only about one third of the 
cases in 2003 and 2004. Due to effi cient screening 
during pregnancy, practically all infected neonates 
in Finland are foreigners. These cases were born 
and infected in countries with inadequate or nonex-
istent screening during pregnancy. In the 2004 sta-
tistics, a third of acute cases were diagnosed in pa-
tients of foreign origin. 
There were still sporadic travel-related cases, 
even though the combined hepatitis A and B vac-
cine has become more and more common among 
travelling Finns over the past decade. In recent 
years more than half of the hepatitis B vaccine used 
in Finland has been administered to travelers.
Chronic hepatitis B
The notifi ed chronic hepatitis B carrier states indi-
cate both infections contracted in the past and cur-
rent potential sources of infection. 
Chronic carrier states accumulate in people of 
foreign origin. In recent years more than half of the 
notifi ed carriers have been of foreign origin, while 
at the same time their proportion of the population 
has been only about three percent. 
Hepatitis B infections that were acquired dec-
ades ago, as a result of the health care system of 
that time, are still detected in elderly people from 
time to time.
HEPATITIS C
Infection of injecting drug users
Based on directed seroepidemiological studies, in 
Finland practically all infections caused by the hep-
atitis C virus (HCV) are related to injecting drug 
use. Before the 1990s blood transfusions, primarily 
fresh blood transfusions, could transmit infections, 
but such cases were rare. 
The infection is nearly always symptomless 
and therefore it is detected coincidentally, in con-
nection with examinations performed for other rea-
sons. The majority of patients develop a chronic in-
fection, and sometimes it may lead to serious liver 
Figure 12.  Acute hepatitis B cases and all hepatitis C cases 19952004.
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disease even decades after becoming infected. To-
day a chronic infection can be treated with medica-
tion.
The data on hepatitis C infections registered 
in the National Infectious Diseases Register are 
based on laboratory diagnosis. Even though phy-
sicians are required to notify all cases, this is not 
always done. One reason may be that the treating 
physicians consider the detected cases old infec-
tions.
The number of registered cases has decreased 
steadily after the peak year 1997 (Figure 12). 
At the same time the number of diagnosed hepatitis 
B and HIV infections has also decreased. These re-
sults confi rm that virus infections related to inject-
ing drugs have decreased markedly in Finland dur-
ing the 2000s. In spite of this, relatively many cases 
are still detected in the youngest (15–24 years) age 
groups (Figure 13). This indicates that preventive 
measures directed to drug users do not optimally 
reach the youngest age groups or have the desired 
effect.
Figure 13.  Hepatitis C in young adults 19952004.
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CHLAMYDIA  THE NUMBER OF CASES 
INCREASED AGAIN 
The favourable declining trend of Chlamydia tra-
chomatis cases in 2003 did not continue in 2004, as 
laboratories notifi ed 13,357 new chlamydia cases, 
exceeding the previous year’s fi gure by 494 cas-
es.  Especially in the hospital districts of Ahve-
nanmaa (354 cases/100,000 population) and Lappi 
(356/100,000) the incidence of chlamydia was clearly 
higher than in the country as a whole (257/100,000). 
Women constituted 60 percent of the cases (8,045). 
Under 20-year-old women constituted 34 percent 
and men 14 percent of all chlamydia cases. The 
highest number of cases was detected in the age 
group 20–24 years, both among men and women.
Since 1995, the surveillance of chlamydia 
has been based on notifi cations by laboratories. A 
new, more sensitive chlamydia test was introduced, 
based on gene amplifi cation methods. The number 
of chlamydia cases increased every year from 1995 
to 2002. In 1995, the number of notifi ed chlamy-
dia cases was 9,317 and in 2002 it was 13,661. The 
greatest increase was in 2002, when the number 
of cases increased by 12.5 percent from the previ-
ous year. The year 2003 was an exception to this 
increasing trend; 12,863 cases were notifi ed then, 
which was 798 fewer than in the previous year. In 
2004, there were 13,356 notifi ed chlamydia cases. 
During the entire period the incidence of chlamydia 
has been highest in the hospital districts of Helsinki 
and Lappi. 
Women constituted 61–63 percent of the diag-
nosed chlamydia cases. The highest number of cas-
es was detected among 20-to-24-year-olds. Particu-
larly the proportion of young cases has increased 
SEXUALLY 
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(Figure 14). The proportion of under 20-year-olds 
has varied from 30 to 37 percent among women 
and from 10 to 15 percent among men. 
The current laboratory notifi cation system 
does not provide information on the country of ori-
gin. According to the data collected by the Sexually 
Transmitted Diseases sentinel surveillance system 
that includes the largest STD policlinics, the major-
ity of chlamydia infections are of domestic origin. 
Less than 10 percent of chlamydia infections are 
contracted abroad.
GONORRHOEA  THE NUMBER
OF GONORRHOEA CASES ALSO INCREASED 
The number of Neisseria gonorrhoeae cases in-
creased in 2004 from the previous year. There were 
251 notifi ed cases in 2004, and 200 (80%) of these 
were male. The incidence in the entire country 
was 4.8/100,000. The highest incidences of gonor-
rhoea cases were detected in the hospital districts 
of Helsinki and Uusimaa (8.6/100,000), Länsi-Pohja 
(7.5/100,000) and Ahvenanmaa (19/100,000). 
The proportion of men’s infections acquired abroad 
has decreased from 45 percent in the preceding 
year to 32 percent. Fifty-fi ve percent of these in-
fections were contracted in the Far East and now 
only 10 percent in Russia. Most strains of gonococ-
ci brought from the Far East are resistant to cipro-
fl oxacin. The majority of women’s gonorrhoea in-
fections (90%) were acquired in Finland; there were 
only fi ve cases contracted abroad.
In 1995–2004, the incidence of gonorrhoea 
has slowly decreased. The highest number of gon-
orrhoea cases was notifi ed in 1995 (378 cases) and 
lowest in 2003 (189 cases). The number of notifi ed 
cases was highest in Helsinki and in the hospital 
districts of Kymenlaakso, Etelä-Karjala and Pohjois-
Karjala, due to the proximity of the eastern border. 
The majority of gonorrhoea cases were diagnosed 
in men (69–85%). Gonorrhoea patients are usually 
older than chlamydia patients. Gonorrhoea is rare 
among under 20-year-olds. Approximately half of 
men’s infections have been contracted abroad. In 
1996, Russia was the country of origin in 56 per-
cent of all infections acquired abroad. Since then 
the proportion of cases with reported origin in the 
Far East has increased continuously. In 2001, infec-
tions contracted in Russia constituted 42 percent 
of all cases acquired abroad and 23 percent were 
Figure 14.  Chlamydia in the age groups of young adults 19952004.
I N F E C T I O U S  D I S E A S E S  I N  F I N L A N D  1 9 9 5  2 0 0 4
35
  1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Infections acquired 
in Finland 185 83 94 100 108 129 113 100 89 133 
Infections acquired 
abroad 130 88 75 98 85 105 80 82 59 72
 Russia 70 50 42 49 42 48 34 28 9 7
 Thailand 9 9 7 16 19 18 17 31 27 38
 Estonia 26 9 7 9 8 7 3 5 2 6
 others 25 20 19 24 16 32 26 18 21 21
Place of acquisition 
unknown 63 55 49 71 62 50 54 53 41 47
Total 378 226 218 269 255 284 247 235 189 252
  1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Domestically acquired 
infectionst 48 53 50 46 21 54 31 24 30 22
Infections acquired 
abroad 64 81 70 60 62 101 64 36 41 29
 Russia 49 57 48 33 43 80 49 21 18 15
 Estonia 5 11 5 5 3 3 2 1 6 1
 Somalia 0 1 2 5 2 0 1 2 2 0
 Thailand 1 0 1 4 0 1 1 0 1 2
 others 9 12 14 13 14 17 11 12 14 11
Place of acquisition 
unknown 57 85 52 81 57 49 64 68 62 55
Total 169 219 172 187 140 204 159 128 133 106
contracted in the Far East, while in 2004 only 10 
percent of such infections were from Russia and 55 
percent from the Far East (Table 7). 
In 2002, a local gonorrhoea outbreak was de-
tected in the Päijät-Häme hospital district, caused 
by a ciprofl oxacin-resistant strain of gonococci 
from Thailand. Gonorrhoea culture remains an im-
portant test method for enabling the surveillance of 
antimicrobial susceptibility.
SYPHILIS  MEN`S INFECTIONS MAINLY 
FROM RUSSIA 
In 2004, there were 106 notifi ed cases of Treponema 
pallidum, clearly fewer than in the preceding year. 
Fifty-fi ve (52%) of the cases were diagnosed in men. 
Twenty-six percent of cases were over 70 years of 
age, but most of these cases involved serological 
scars due to previously treated syphilis. 
The highest incidences were notifi ed in 
the hospital districts of Helsinki and Uusimaa 
(4/100,000), Etelä-Karjala (4.6/100,000) and Etelä-
Savo (4.8/100,000). Only 24 percent of men’s infec-
tions were acquired abroad, most of these (46%) in 
Russia. The majority (82%) of women’s infections 
were acquired in Finland. 
In 1995–2004, the number of syphilis infec-
tions has decreased slowly. The highest number 
of syphilis cases was notifi ed in 1996 (219) and the 
lowest in 2004 (105) (Table 8). There was a syphilis 
Table 7.  Gonorrhoea infections acquired domestically and abroad 19952004.
Table 8.  Syphilis infections acquired domestically and abroad 19952004.
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outbreak in the Tampere region in 1995, but there 
have been no such outbreaks since then in Finland. 
Each year 10–27 percent of the infections were noti-
fi ed in patients over 70 years of age, but these cases 
were usually related to serological scars due to a 
previous syphilis infection. Men constituted 52–63 
percent of diagnosed cases. The average age of 
syphilis patients was approximately 30–45 years. 
The highest incidences of syphilis have been 
detected in the hospital districts of Etelä-Karjala, 
Pohjois-Karjala and Kymenlaakso, due to infec-
tions acquired in Russia. Of men’s infections 58–75 
percent were contracted abroad, usually in Russia. 
Women’s infections were mainly acquired in Fin-
land. Positive syphilis serology is detected every 
year in about ten pregnant women in the screen-
ings performed by maternity clinics. 
HIV AND AIDS  CASES CONTINUE TO 
DECLINE AMONG INJECTING DRUG USERS
In 2004, there were 130 new HIV infections detect-
ed in Finland. As regards HIV infections related 
to injecting drugs, the favourable trend continued 
in 2004: preliminary data show that only ten cas-
es were associated with the use of injecting drugs 
(Figure 15). Compared with the epidemics in many 
of our nearby regions, the preventive measures di-
rected at this risk group seem to have succeeded in 
Finland. 
However, cases associated to sex between 
men have been slightly on the increase for several 
years (Figure 15). 
HIV infections contracted in sex between men 
and women increased slowly, particularly among 
Finnish men (Figure 16). In 1980–2004 there were 
1,754 HIV infections diagnosed in Finland, 74 per-
cent of them in Finns.
Sex is the most common mode of transmission
Among Finnish HIV cases, infections acquired in 
sex between men still constitute the largest trans-
mission category (42% of cases), the next largest 
category is sex between men and women (28%), 
and the third most signifi cant category is injecting 
drug use (21%), despite the recent favourable devel-
opment. Transmission from mother to child is very 
Figure 15.  HIV cases detected among Finns in 19802004 in the major transmission categories.
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rare. Since 1985 there have been no notifi ed infec-
tions transmitted by blood products in Finland.
Hiv epidemic among injecting drug users 1998
Throughout the 1980s and during the fi rst half of 
the 1990s only a few HIV infections associated with 
injecting drug use were diagnosed in Finland, in 
contrast to the other Nordic countries and all of 
Western Europe. Before 1998, only 27 sporadic 
cases had been detected (3% of all diagnosed cas-
es), and none of these led to an outbreak. In 1998, 
an outbreak appeared among injecting drug users, 
and it peaked the following year. Eighty-fi ve new 
infections were diagnosed then. When the out-
break appeared, control measures were started im-
mediately: more health counselling centres with a 
broader spectrum of services for injecting drug us-
ers were established rapidly both in the capital re-
gion and elsewhere in Finland. At fi rst the epidem-
ic remained mainly in the capital region. The health 
counselling centres have yielded results: since 1999, 
the number of detected HIV infections associated 
with injecting drugs has decreased every year. In 
addition, seroepidemiological prevalence studies 
conducted at the health counselling centres indicate 
that the number of persons positive for HIV has re-
mained low in this group. Subtype determinations 
have also shown that the majority of cases are still 
related to the HIV-1 CRF01-AE subtype that caused 
the original epidemic and is common in Southeast 
Asia (Figure 17). The A type that is common in this 
transmission category in East Europe has caused 
only four diagnosed infections in Finland. The sub-
type CRF06, common in Estonia, had not been de-
tected in this transmission category by the end of 
2004.
The number of infections associated with sex 
between men increased at fi rst between 1985 and 
1990 to its peak level so far, after which the annual 
number of cases stabilised and then decreased dis-
tinctly at the end of the 1990s, but began to increase 
again at the beginning of the 2000s. The trend in 
Finland is similar to that in Central Europe and 
North America. HIV-1 subtype B is dominant in the 
category of sex between men, and constitutes 95 
percent of all cases in Finland (Figure 17). The lim-
ited distribution of subtypes indicates that this sub-
Figure 16.  HIV infections acquired through sex between men and women in 19802004.
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category of the Finnish epidemic is fairly homog-
enous. 
Infections from heterosex 
are associated with travelling
As regards HIV infections acquired in sex be-
tween men and women, the number of male cases 
has grown year by year, while the number of cas-
es among women has remained at the same level. 
A signifi cant proportion of the cases are associ-
ated with travelling abroad, both among men and 
women. Sixty-six percent of typed strains among 
men are of some other subtype than the B com-
mon in the Western countries, and among women 
the corresponding fi gure is 70 percent (Figure 17). 
The most common HIV-1 subtype in this catego-
ry is CRF01-AE (22% of cases), common in South-
east Asia, followed by the C (18%) and A (8%) sub-
types. The CRF01-AE-Fin strain, originally related 
to injecting drugs, has been detected in 13 patients 
in this category. Only six patients in the category 
have been diagnosed with HIV-1 strains common in 
Eastern Europe. The subtype disribution supports 
the impression that a signifi cant proportion of cases 
acquired in heterosexual contact is travel-related 
(Table 9).
Among cases diagnosed in foreigners, infec-
tions related to sex between men and women con-
stitute the largest category (about 60% of cases), 
and the proportion of infections related to sex be-
tween men is relatively small, only about 13 per-
cent. The percentage of infections transmitted from 
mother to child (the great majority before arrival in 
Finland) and the percentage of infections with un-
known origin were higher than among Finns. Infec-
Figure 17.  The HIV subtype distribution in the main transmission groups of Finnish cases between 1998-2004 (No. typed/total).
I N F E C T I O U S  D I S E A S E S  I N  F I N L A N D  1 9 9 5  2 0 0 4
39
Mode of transmission    
 
Cases 
Year Females Males Total Homosexual Heterosexual Blood  IV drugs From mother Unknown
    contact contact products  to child
1995 28 44 72 25 40 0 1 0 6
1996 20 49 69 23 36 0 1 0 9
1997 24 47 71 19 42 0 0 1 8
1998 32 49 81 13 32 0 20 0 16
1999 39 104 143 13 28 0 86 1 14
2000 51 94 145 23 43 1 56 2 18
2001 33 95 128 27 25 0 49 0 26
2002 37 94 131 38 41 0 27 3 22
2003 40 92 132 30 54 0 23 1 23
2004 25 104 129 44 53 1 10 1 20
* The latest transmission by blood products in Finland was detected in 1985.
tions related to injecting drugs constitute a relative-
ly lower percentage among the cases diagnosed in 
foreigners. It is remarkable that the HIV epidemics 
of these two groups, Finns and foreigners, really 
are separate from each other, and with a few excep-
tions hardly any infections are transmitted between 
the groups. In the group of foreign cases, other 
subtypes than subtype B are dominant. Foreigners’ 
infections refl ect almost solely the epidemiological 
situation in the country of origin. 
AIDS  decreased mortality 
due to effective medication 
Nineteen HIV-positive patients were notifi ed to 
have developed aids in 2004. Among them, 15 in-
fections had been transmitted sexually and four by 
injecting drugs. Four aids patients died. Compared 
with 1995, when 41 patients developed aids and 40 
died, the numbers of patients developing aids and 
dying from it have decreased remarkably. The most 
important factor in this progress has been the avail-
ability of effi cient HIV medication since the end of 
the 1990s.
Table 9.  HIV cases by mode of transmission 19952004.
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TUBERCULOSIS  THE NUMBER OF CASES 
CONTINUES TO DECREASE 
Since 1995 the registered cases include all cases of 
tuberculosis verifi ed by culture, as notifi ed by the 
laboratories. In addition, cases notifi ed by a physi-
cian only are included if the diagnosis is confi rmed 
by histology or a case of pulmonary tuberculosis is 
confi rmed by positive sputum staining for tubercu-
losis bacilli.
The number of diagnosed tuberculosis cases 
in 2004 was 347 (Table 10), indicating a continuing 
decrease, by 16 percent from 2003. In 2004, there 
were 259 cases (75%) based on notifi cation by both 
a physician and a laboratory, 44 cases (13%) based 
on laboratory notifi cation only and 44 cases (13%) 
based on a physician’s notifi cation fulfi lling the re-
porting criteria.
The favourable development of the previous 
decades continued in Finland, as the incidence of 
tuberculosis (Table 10) fell to one half between 1995 
and 2004 (12.9 → 6.6/100,000). The fall is unusual-
ly fast for an industrialised country. Even though 
the incidence has decreased strongly in all age 
groups (Figure 18), the most signifi cant change in 
the number of cases can be seen in the age groups 
of high incidence, i.e., the over-65-year-olds. This 
is due to the shrinking of the age groups that con-
tracted an infection in their youth before the 1950s, 
predisposing them to reactivation of tuberculosis 
later in life. On the other hand, the small number of 
immigrants to Finland from countries of high inci-
dence explains the small number of cases among the 
working-age population in comparison with most 
other industrialised countries where the percentage 
of immigrants among the population is clearly high-
er. Both physicians and laboratories are individu-
ally obliged to notify tuberculosis. The majority of 
MYCOBACTERIAL INFECTIONS
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Figure 18.  Incidence of tuberculosis by age group in 1995 and 2004.
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Year  Pulmonary tuberculosis Other tuberculosis All cases
 Cases Incidence/ Positive Incidence of Cases Incidence/ Cases  Incidence/ Culture- Proportion of
  100,000 sputum positive  100,000  100,000 conÞ rmed culture conÞ r-
    sputum stains/     cases med cases (%)
    100,000
    
1995 438 8,5 244 4,7 224 4,4 662 12,9 472 71,3
1996 432 8,4 241 4,7 213 4,1 645 12,5 510 79,1
1997 363 7,1 188 3,7  212 4,1 575 11,2 435 75,7
1998 396 7,7 201 3,9  233 4,5 629 12,2 491 78,1
1999 382 7,5 180 3,5  184 3,6 566 11,1 487 86,0
2000 370 7,2 228 4,4 167 3,2 537 10,4 451 84,0
2001 316 6,1 159 3,1 178 3,4 494 9,5 411 83,2
2002 297 5,7 137 2,6 177 3,4 474 9,1 392 82,7
2003 292 5,6 148 2,8 123 2,4 415 8,0 347 83,6
2004 235 4,5 128 2,5 112 2,1 347 6,6 289 83,5
 
the latter submit their notifi cations electronically to 
the National Infectious Diseases Register. It is highly 
unlikely that declining notifying activity could ex-
plain the decreased number of cases.
Diagnostic categories and proportion 
of infective patients
The proportion of culture-confi rmed cases of all 
cases of tuberculosis registered in the National In-
fectious Diseases Register has varied over the years 
from 71 to 86 percent (Table 10). Since 1999 the pro-
portion has remained stable. The proportion of cul-
ture-confi rmed infections among the cases of pul-
monary tuberculosis has been around 90 percent in 
recent years. The proportion of infective pulmonary 
tuberculosis with a positive sputum stain of all pul-
monary tuberculosis cases has varied in 1995–2004, 
from 46 to 62 percent (54% in 2004), but no particu-
lar trend is visible in this proportion during this pe-
riod.
Table  10.  Incidence of tuberculosis in Finland 19952004.
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Figure 19.  Infections in Finns and persons of foreign origin by age group in 2004.
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Year  Pulmonary tuberculosis Other tuberculosis All cases
 Cases detected in  Proportion of Cases detected in Proportion of Cases detected in Proportion of
 foreigners foreigners (%) foreigners foreigners (%) foreigners foreigners (%)  
1995 25 5,7 12 9,4 37 5,6
1996 17 3,9 22 10,3 39 6,1
1997 22 6,1 23 15,1 45 7,8
1998 24 6,1 32 13,7 56 8,9
1999 25 6,5 20 10,9 45 8,0
2000 31 8,4 16 9,6 47 8,4
2001 38 12,0 28 15,7 66 13,4
2002 23 7,7 26 14,7 49 10,3
2003 37 12,7 13 10,6 50 12,0
2004 22 9,4 18 16,2 40 11,6
Children
It is particularly diffi cult to confi rm tuberculosis 
microbiologically in children under 15. Forty-four 
cases altogether were registered in the National In-
fectious Diseases Register for this age group (1995–
2003 N=39, 2004 N=9), which gives an average of 
4 cases per year throughout the ten-year period.  
Thirty (68%) of these cases were diagnosed in per-
sons of foreign origin. In addition to the cases reg-
istered in the National Infectious Diseases Register, 
treating physicians have notifi ed 0–8 cases a year 
detected in children under 15 (three cases per year 
on average) with such a strong clinical suspicion of 
tuberculosis that full anti-tuberculosis treatment has 
been decided on without microbiological confi rma-
tion of the diagnosis.
Table 11.  Tuberculosis infections detected in foreigners 19952004.    
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Foreigners
The number of notifi ed infections in foreign-
ers (born abroad or a citizen of another country) 
did not increase in 1995–2004 (Table 11). While 
the number of Finns diagnosed with tuberculosis 
is rapidly decreasing, the proportion of foreign-
ers among all notifi ed cases has nearly doubled. In 
2004, thirty-fi ve (88%) of the notifi ed cases in for-
eigners were diagnosed in patients under 55 years 
of age (Figure 19). Most of the notifi ed foreign cases 
have their origins in countries with a high incidence 
of tuberculosis. In 1995–2004, forty-seven percent of 
foreign tuberculosis cases originated from Africa, 
29 percent from Asia and 14 percent from the area 
of the former Soviet Union.
Multidrug resistant strains
As regards the antimicrobial susceptibility of Myco-
bacterium tuberculosis strains, the situation has re-
mained good in Finland, even though strains resist-
ant to both isoniazid and rifampicin, ie multidrug 
resistant (MDR), strains are common in Russia and 
Estonia. No multidrug resistant strains were noti-
fi ed in 2004; in the previous years the number has 
been 2–4 per year (0.4–1.0%).
Molecular epidemiology of 
tuberculosis in Finland 20002004
Molecular epidemiology typing of Mycobacterium 
tuberculosis strains is an essential part of tracing 
the transmission routes of tuberculosis. The Myco-
bacterial Reference Laboratory of the National Pub-
lic Health Institute collects all new M. tuberculosis 
strains as part of the strain collection maintained by 
the National Infectious Diseases Register. 
Finland’s M. tuberculosis strains have been 
tested systematically by internationally standard-
ised typing methods (IS6110 RFLP and spoligotyp-
ing). Altogether 1,876 strains were tested in 2000–
2004. The results indicate that about 40 percent of 
Finnish cases belong to clusters. The size of the 
clusters varied from 2 to 38 cases/cluster, the me-
dian being two cases. Belonging to a cluster usually 
means a fresh infection and epidemiological con-
nection between the cases. The infection can also 
be due to reactivation of a formerly common strain 
in an aging person, which is not uncommon in Fin-
land.
Eleven fresh TB infection clusters of more 
than ten cases were detected. The largest of these is 
a cluster of 38 cases, the fi rst of the cases a dog that 
in turn transmitted TB to its owner. Most of the oth-
er patients in the cluster were homeless men from 
Helsinki. The only obvious connection between 
the dog and the homeless men was an outdoor 
area that all of them visited. This TB strain has also 
spread to other parts of Finland, but the spreading 
seems to have stopped for the time being, as new 
cases were no longer detected in 2004.
Genotyping has revealed fi ve laboratory con-
taminations. These involved 36 persons altogeth-
er. Six of them had strongly positive samples as the 
source of cross-contamination to the cultures of 
30 other persons. As the contaminations were re-
vealed, unnecessary treatments and tracing of in-
fections were avoided. 
Typing has also revealed that strains of the 
so-called Beijing group, common in the nearby 
regions, are rare in Finland. These M. tuberculo-
sis strains spread faster, and they are often MDR 
strains. About two percent of Finnish strains be-
long to the Beijing group, and only a few of them 
have been MDR strains. So far there have been no 
outbreaks caused by an MDR-TB strain in Finland.
BCG
The Mycobacterium bovis BCG bacterial strain is 
a strain attenuated for vaccination, derived from 
the bacterial species M. bovis belonging to the M. 
tuberculosis complex.  Adverse effects caused by 
the BCG vaccine in the vaccination programme in-
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Figure 20.  M. bovis BCG -infections 19952004.
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Mikrobe Findings Proportion
Mycobacterium avium 1360 34 %
Mycobacterium gordonae 943 24 %
Mycobacterium intracellulare 398 10 %
Mycobacterium fortuitum 219 6 %
Mycobacterium malmoense 170 4 %
Mycobacterium chelonae 86 2 %
Mycobacterium terrae 69 2 %
Mycobacterium avium complex 46 1 %
Mycobacterium peregrinum 39 1 %
Mycobacterium abscessus 35 1 %
Mycobacterium marinum 29 1 %
Mycobacterium xenopi 27 1 %
other atypical mycobacteria 540 14 %
Total 3961 100 %
creased after switch of the source of the vaccine 
in August 2002. This was refl ected as a rise in the 
number of M. bovis BCG fi ndings notifi ed to the 
National Infectious Diseases Register (Figure 20). 
Nearly all fi ndings were obtained from lymph node 
samples. In 2004, the number of notifi ed fi ndings 
decreased clearly. A similar trend was seen in the 
number of BCG vaccination-related adverse effects 
notifi ed to the National Public Health Institute. The 
number of cases peaked in 2003 and decreased the 
following year. Similar increases of adverse effects 
after changing a vaccine have been reported before. 
The fi ndings notifi ed by laboratories also include 
fi ndings related to local treatment of bladder cancer 
with M. bovis BCG bacterium.
ATYPICAL MYCOBACTERIA 
Laboratories also notify the fi ndings of atypical my-
cobacteria to the National Infectious Diseases Reg-
ister. In 1995–2004, M. avium was clearly the most 
common fi nding notifi ed, constituting more than a 
third of all fi ndings (Table 12).  More than 100 cases 
of M. gordonae, M. intracellulare, M. fortuitum and 
M. malmoense were also notifi ed during this peri-
Table 12.  The most common Þ ndings of atypical 
mycobacteria 19952004.
od.  There was no signifi cant annual variation in the 
distribution of the most common species. The viru-
lence of this group of bacteria varies. Usually they 
cause so-called opportunistic infections in persons 
with impaired immunity.
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MRSA  THE SITUATION CONTINUED 
TO DETERIORATE  
The number of infections caused by methicillin-re-
sistant Staphylococcus aureus (MRSA) continued to 
increase in 2004. Now this development manifested 
in severe systemic infections for the fi rst time. Near-
ly 1,500 MRSA cases were notifi ed to the National 
Infectious Diseases Register. The hospital districts 
of Helsinki and Uusimaa, Pirkanmaa and Pohjois-
Pohjanmaa had the highest numbers of cases. In-
cidence per 100,000 population was highest in the 
hospital districts of Pirkanmaa, Helsinki-Uusimaa 
and Satakunta (Figure 21).
 MRSA increased particularly among the eld-
erly. In recent years the proportion of over 74-year-
olds has been nearly half of all cases. Even though 
MRSA was rare in children (<6% of cases), the 
number of infections among children under 1 year 
of age increased, too (Figure 22).
KTL conÞ rms and types all MRSA strains
KTL’s Laboratory of Hospital Bacteriology confi rms 
and types all MRSA strains in Finland. In 2004, 
more than 1,700 strains were tested, which is one 
third more than in 2003. Approximately half of the 
confi rmed MRSA infections were caused by two 
multiresistant epidemic strains (Töölö and Bel EC-
3 epidemic strains). Other epidemic strains detect-
ed in previous years (Kokkola, Kemi and Mikkeli 
clones) were also common in many hospital dis-
tricts. 
Findings in blood
There were 32 MRSA fi ndings from blood, and 
three were from cerebrospinal fl uid. Previously 
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there has been only one MRSA fi nding from cer-
ebrospinal fl uid, in 1998. In 1995–2003, MRSA fi nd-
ings from blood were sporadic, and the proportion 
of methicillin-resistant Staphylococcus aureus fi nd-
ings from blood remained below one percent. Now 
the proportion of MRSA strains among S. aureus 
fi ndings from blood rose above 2.5 percent (Table 
13). 
One third of the MRSA fi ndings from blood 
occurred in the hospital district of Helsinki and 
Uusimaa. It is also of importance to note that the 
total number of S. aureus fi ndings from blood in-
creased by nearly 70 percent from 1995 to 2004 
(from 12 to 20 cases per 100,000 population).  Most 
of the increase occurred among adults, with em-
phasis on the oldest age groups.
S. aureus is a typical cause of hospital infec-
tions. In the hospital infection surveillance pro-
gramme SIRO, S. aureus was the second most com-
mon microbe in 1999–2003 in both blood culture 
positive hospital infections (11%) and surgical site 
infections (18%), but hospital infections caused by 
MRSA were rare. Among blood culture positive Figure 21.  MRSA cases by hospital district 19952004.
Figure 22.  Age distribution of MRSA cases 19952004. 
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Year All MRSA-Þ ndings S. aureus blood culture MRSA blood culture Þ ndings and 
  Þ ndings the meticillin resistance of S. aureus (%)
1995 89 627 2 (0,3) 
1996 108 667 0 (0) 
1997 120 747 4 (0,5)
1998 189 717 5 (0,7)
1999 211 812 8 (1,0)
2000 261 849 4 (0,5)
2001 340 887 4 (0,5)
2002 599 988 10 (0,9)
2003 851 978 7 (0,7)
2004 1460 1057 32 (2,9)
Total 4227 8329 76 (0,9)
infections caused by S. aureus the proportion of 
MRSA was one percent (5/437) and in surgical site 
infections three percent (4/128).
New guidelines for control in 2004
In summer 2004, a Finnish group of experts com-
pleted revised guidelines for the control of MRSA 
infections in health care institutions. The guidelines 
are intended to help infection control teams in hos-
pital districts and institutions in planning and im-
plementing control measures against MRSA. The 
guidelines (in Finnish) are available in pdf form on 
KTL’s website at http://www.ktl.fi /attachments/
suomi/osastot/infe/julkaisut/mrsa2004.pdf
VRE
The number of fi ndings notifi ed to the Nation-
al Infectious Diseases Register in 2004 was only 
14, which is at the same level as in 2001–2003. No 
VRE fi ndings were made from blood or cerebrospi-
nal fl uid. More than 80 percent of all VRE notifi ca-
tions in 1995–2004 came from the hospital district 
of Helsinki and Uusimaa, particularly in the years 
1996–2000 (VRE outbreaks in the capital region). 
VRE clusters with approximately ten cases each oc-
curred in the Vaasa hospital district in 1999–2000 
and in Pohjois-Pohjanmaa in 2004. Some sporad-
ic VRE fi ndings were made annually in the hospi-
tal district of Varsinais-Suomi. In 1995–2004, there 
were altogether only four VRE fi ndings from blood 
(and none isolated from cerebrospinal fl uid).
In 2004, KTL’s Laboratory of Hospital Bacte-
riology confi rmed a total of 18 new VRE cases by 
bacterial typing. Epidemic VRE strains of vanB type 
Enterococcus faecalis and vanB type E. faecium spe-
cies were detected in Pohjois-Pohjanmaa (11 cases 
altogether); the rest of the VRE strains of E. fae-
cium species, detected in different parts of Finland 
(7 cases altogether), were different from each other. 
Five different epidemic VRE strains and a number 
of sporadic VRE strains have been identifi ed in Fin-
land by bacterial typing in 1996–2004.
PNEUMOCOCCUS
Invasive pneumococcal disease  susceptibility of 
pneumococcus to macrolides and penicillin 
The incidence of invasive Streptococcus pneumoni-
ae disease was approximately 10 cases per 100,000 
Table 13.  MRSA Þ ndings and their proportion of S. aureus blood culture Þ ndings 19952004.
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Year Cases reported Examined Erythromycin Penicillin (I+R) Multidrug
 to the National strains (%) (%) resistance (%)
 Infectious Diseases
 Register
1998 561 84 3,6 0 0
1999 568 471 5,9 7,2 0
2000 601 439 8,0 3,7 1,4
2001 658 360 18,8 7,5 5,0
2002 599 594 16,3 8,0 3,7
2003 721 739 21,9 12,7 5,7
2004 748 748 20,5 9,6 3,7
population in 1995–2002. In 2003, the incidence rose 
by a third (13/100,000 population). The incidence 
rose in all age groups, and it was associated with 
the strong infl uenza A epidemic that occurred at the 
end of the year. In 2004, the incidence remained at 
the same level as in 2003.
The proportion of pneumococci resistant to 
macrolides was about six percent in 1999, but it 
has subsequently risen rapidly. In 2003, the pro-
portion of macrolide-resistant strains was already 
more than 20 percent. Resistance to macrolide was 
more common among children than adults (31% vs 
18%). Previous studies have already shown that the 
resistance of pneumococci to macrolides is associ-
ated with the increased consumption of macrolides. 
The use of macrolides has increased considerably 
in Finland in recent years, which may be the reason 
behind the increased resistance.
The proportion of strains with reduced sus-
ceptibility to penicillin (MIC 0.125-<2 mg/L) also 
grew. They were most common in children under 
two years of age (12%). The proportion of penicil-
lin-resistant (MIC ≥2 mg/L) strains remained below 
three percent. These strains were most common in 
those aged 65 or more (4%) and least common in 
children under two (less than 1%). In 1999, no mul-
tiresistant pneumococcal strains were found yet. In 
2000, their proportion was more than one percent, 
and in 2001–2004 it varied between 4 and 6 percent. 
Multiresistant pneumococcal strains were detected 
in all age groups, but their proportion was highest 
among children under two (6%) and among cases 
aged 65 years or more (6%).
The most common pneumococcal serotypes 
causing invasive infections were 14, 4, 9V, 3, 23F 
and 7F. In 2002–2004, these serotypes caused ap-
proximately half of all invasive pneumococcal infec-
tions. During these years the distribution of sero-
types has remained almost unchanged. Resistance 
to macrolides and penicillin was detected partic-
ularly in serotypes 14 and 9V. Resistance to mac-
rolides was also common in serotypes 19A, 6B, 7F 
and 19F. With the exception of serotype 7F, these 
serotypes also often showed reduced susceptibility 
to penicillin. Most multiresistant strains were of se-
rotype 14 (Table 14 and 15).
Table 14.  Antimicrobial resistance of Streptococcus pneumoniae Þ ndings in blood and CSF 19982004.
I  reduced susceptibility; R  resistant; Multidrug resistance  strains simultaneously resistant to penicillin, erythromycin 
and tetracycline
I N F E C T I O U S  D I S E A S E S  I N  F I N L A N D  1 9 9 5  2 0 0 4
49
 Serotype Pneumococcal strains Erythromycin(%) Penicillin (I+R) (%) Multidrug resistance (%)
 14 289 55 33 144 
 4 252 6 2 1
 9V 172 39 16 2
 3 162 2 2 <1
 23F 141 9 6 2
 7F 132 2 3 <1  
The situation in Finland the 
worst among the Nordic countries
The European Antimicrobial Resistance Sur-
veillance System EARSS, launched in 1999, 
http://www.earss.rivm.nl, collects antimicrobial 
susceptibility data on only invasive microbe iso-
lates: S. aureus, E. coli and enterococci from blood 
and pneumococci from both blood and cerebrospi-
nal fl uid.  In 1999–2004, nine to fi fteen FiRe labora-
tories http://www.ktl.fi /extras/fi re out of Finland’s 
28 clinical microbiology laboratories participated 
in EARSS. The susceptibility results for S. aureus 
and enterococci were very similar to the data in 
the National Infectious Diseases Register. Signs 
of the deteriorating MRSA situation could already 
be seen in the EARSS report in 2003, as the pro-
portion of methicillin-resistant strains exceeded 
one percent (1.4%, 10/727). In 2004, the proportion 
of probable extended-spectrum -lactamase-produc-
ing strains (ESBL) of all E. coli strains rose above 
one percent for the fi rst time, and the proportion 
of strains resistant to fl uoroquinolones was seven 
percent. From 1999 to 2004 the resistance of pneu-
mococcus to macrolides rose from six to nineteen 
percent.
Overall, the antimicrobial resistance situation 
in Finland is worse than in the other Nordic coun-
tries and the Netherlands as regards the invasive 
microbial pathogens mentioned above, but better 
than the situation in Central and Southern Europe. 
The most signifi cant changes in recent years have 
been taking place in the MRSA situation, the sus-
ceptibility of pneumococci to macrolides and the 
emergence of invasive ESBL strains
Table 15.  The most common Streptococcus pneumoniae serotypes and their antimicrobial resistance 20022004.
I  reduced susceptibility; R  resistant; Multidrug resistance  strains simultaneously resistant to penicillin, erythromycin 
and tetracycline
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HIB  VACCINE PROVIDES GOOD PROTECTION 
In 2004, the National Infectious Diseases Register 
received notifi cations on 27 cases of serious infec-
tions caused by the Haemophilus infl uenzae bacte-
rium, detected from blood or cerebrospinal fl uid. 
Haemophilus infl uenzae type b caused disease only 
in one elderly patient. 
The other infections were also detected main-
ly in adults; only three of the cases belonged to the 
age group 0–14 years. 
Children born in 1985 and later have received 
Hib vaccination since 1986 at the healthy child clin-
ics at the age of four, six and 14–16 months. Only a 
few years after the vaccinations began, the number 
of Hib cases decreased from hundreds to a few 
cases per year. At the beginning of the 2000s there 
were years when no cases at all were diagnosed in 
the vaccinated age groups, while in some years spo-
radic cases were detected among those who had re-
ceived a partial or full series of vaccinations.
Since the beginning of 2005, according to the 
revised vaccination programme, Hib vaccination is 
administered as a component of a combination vac-
cine at the age of three, fi ve and twelve months. 
The effi cacy of the vaccination is monitored 
closely, and information on vaccinations is inves-
tigated on all children in the age group vaccinated 
who have been diagnosed with Hib (Table 16).
MENINGOCOCCUS  NO VARIATION
IN THE NUMBER OF CASES 
The number of Neisseria meningitidis cases noti-
fi ed to the National Infectious Diseases Register 
has varied very little (42–58 cases/year) since 1997, 
and the incidence has been low (0.8–1.1/100,000). 
OTHER INFECTIONS
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Year Hib cases Vaccinated cases Age 04 years Age 515 years  Age > 15 yeras 
 
1995 6 2 1 2 3 13
1996 5 - - - 5 21
1997 2 1 - 2 - 17
1998 4 - 2 - 2 32
1999 7 3 2 1 4 32
2000 2 2 2 - - 37
2001 4 - - - 4 49
2002 4 -  - - 4 26
2003 8 4 4 2 2 36
2004 1 - - - 1 27
Haemophilus inß uenzae type b cases
In 1995 and 1996, there were 78 and 79 cases, with 
incidences of 1.52 and 1.53/100,000, respectively. A 
strain was sent to the National Public Health Insti-
tute in more than 90 percent of the notifi ed cas-
es. The majority of cases were caused by group B 
meningococci. Fewer than ten group C strains per 
year were detected in 1997–2004, which was also 
the case with group Y strains. Group W135 strains 
began to appear after the turn of the millennium. 
An infection cluster caused by group B 
meningococcus, a strain of subtype B:15, emerged 
in 1994 causing concern.  The cases were conscripts 
from the Parola and Riihimäki garrisons and per-
sons who had been in close contact with them. 
In addition, group C meningococci fi ndings were 
more abundant than usual in these years (Table 17). 
The group C pathogens represented different strain 
types. About half of these cases were detected in 
the province of Western Finland. B:2b was the third 
subtype that increased at the same time. After 1996 
the number of cases decreased for both group B 
and group C. 
Most meningococcal infections occur among 
small children and young adults. There have been 
10–20 cases per year among children under 15. A 
rising incidence in older age groups has been re-
garded as a sign of an early stage of a possible epi-
demic. In 1995 and 1996, the increase in cases was 
to a great extent due to an increased number of cas-
es in adults; in these years 30 and 32 cases, respec-
tively, were notifi ed in 15–24-year-olds, and after 
that 8–19 cases per year. 
The clusters in 1995–1996 increased the in-
cidence in the provinces of Southern Finland and 
Western Finland (1.3–2.2/100,000). After this, cas-
es have been detected evenly all over the country 
with the exception of Lapland, where the incidence 
in 1998, 1999, 2003 and 2004 was about twice as 
high as in the rest of Finland (2.01–2.13/100,000). In 
Åland there was only one diagnosed meningococcal 
infection during the entire period, in 1995.
Judging by the subtyping results, group B 
meningococcal strains have been very heterogene-
ous in Finland. With few exceptions, the subtypes of 
the strains have been very different, and only four 
group B subtypes were detected in at least three 
strains per year during several years. The propor-
tions of types B:4 and B:4:4 varied throughout the 
surveillance period. The B:2b subtype strains com-
mon in the 1990s have been rare in the 2000s. The 
B:15 subtype that caused the 1995–1996 cluster was 
detected in 1999 and 2000 only in three cases alto-
gether. After this the B:15 strains have increased 
again so that in 2001–2004 a total of 21 strains were 
Table 16.  Invasive Hi and Hib cases 19952004.
All Haemophilus
inß uenzae cases
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Year Group A Group B Group C Group Y  Group W135 Unknown Total
 
1995 - 50 22 - - 6 78
1996- - 59 15 3 - 2 79
1997 - 59 15 3 - 2 79
1998 - 44 7 2 - 1 54
1999 - 35 9 8 1 4 57
2000 - 30 11 2 3 2 48
2001 - 34 9 4 1 3 51
2002 - 36  6 4 1 2 49
2003 - 28 5 7 - 2 42
2004 - 32 5 4 2 4 47
detected. Most of the cases were young adults par-
ticularly in the Häme region. It seems that the sub-
type that caused the cluster in 1995–1996, is still 
going around in Finland.  
MMR  VACCINE PROVIDES 
GOOD PROTECTION 
Measles, mumps and rubella (the MMR diseases) 
were eradicated from Finland by the mid-1990s due 
to a successful MMR vaccination programme. En-
demic cases have not been detected in our country 
since then.  Laboratory-confi rmed cases in 1995–
2004, fewer than 10 per year for each of these dis-
eases, have been imported into Finland by travel-
lers. All cases have been non-vaccinated. In 2004, 
only one case of mumps was detected, imported 
from Somalia, but not a single case of measles or 
rubella. Over the years the National Infectious Dis-
eases Register has received a number of notifi ca-
tions of suspected MMR cases that confi rmation 
tests and investigations have revealed as post-vac-
cination antibody rises or cross reactions, etc., in-
stead of real cases.
WHO has set strategic objectives to eliminate 
measles and control rubella (<1 congenital rubel-
la infection /100,000 births) by 2010 in the Euro-
pean region. In order to achieve these objectives, 
the proportion of children having received at least 
one dose of measles-rubella vaccine should exceed 
95 percent. In addition, the proportion of women 
in childbearing age having received rubella vacci-
nation should be >90 percent. In order to achieve 
mumps control the vaccination coverage should 
also exceed 90 percent. Finland has achieved all 
these objectives. Since the end of the 1980s the 
MMR vaccination coverage has exceeded 95 per-
cent. 
Seroepidemiological studies have shown that 
at the end of the 1990s, 2.7 percent of under 10-
year-olds, 2.1 percent of 10–20 year-olds, 1.4 per-
cent of 20–40-year-olds and less than one percent 
of over 40-year-olds were negative for measles an-
tibodies.  As regards rubella, only 1–4 percent of 
all under 40-year-olds were seronegative, while the 
proportion of those negative for mumps antibodies 
was somewhat higher.
As part of the campaign to eradicate mea-
sles, the occurrence of different viral strain types is 
monitored globally by WHO’s measles-rubella ref-
erence laboratory network. Some strains of MPR 
viruses imported into Finland from different parts 
of the world in the past ten years have been identi-
fi ed genetically to belong to a common subtype in 
Table 17.  Meningococcal infections by serogroup 19952004.
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025 cases / 100 000 inhabitants
2650 cases / 100 000 inhabitants
5175 cases/ 100 000 inhabitants
76100 cases/ 100 000 inhabitants
over 100 cases / 100 000 inhabitants
their region of origin. These imported cases have 
not spread, which proves that the protection level 
is still suffi cient in Finland. The eradication of MMR 
diseases succeeded in Finland due to high vaccina-
tion coverage.
The atypical, often milder-than-usual-disease 
forms occurring in the vaccinated may complicate 
the confi rmation of suspected infections. A low-
threshold approach in taking samples as early as 
possible and sending them to a laboratory for con-
fi rmation guarantees reliable surveillance of MMR 
diseases in the future as well.
EPIDEMIC NEPHROPATHY  PEAK 
INCIDENCE FROM AUGUST TO DECEMBER 
In 1994–2004 there were nearly 14,000 notifi ed cases 
of epidemic nephropathy caused by the Puumala vi-
rus. Sixty-three percent of the patients were male, 
and 80 percent were 25–64 years old. The incidence 
of epidemic nephropathy among 25–44-year-old 
men is twice as high as among women in the same 
age group. Among those over 65 years of age the in-
cidence was equally high among men and women.
There is seasonal variation in the incidence of 
epidemic nephropathy, with the highest number of 
cases occurring in December each year. Another in-
cidence peak in 1995–1997 could be seen in August. 
In addition, in the winters of two consecutive years 
there are more cases than in the third year. This 
yearly and seasonal variation has been associated 
with the three-year cyclical variation of the bank 
vole population density, and on the other hand with 
bank voles seeking their way to houses and sheds 
early in the winter, which increases the likelyhood 
of Puumala virus exposure for humans. 
A particularly high number of cases was diag-
nosed in December 1998, December 1999, Decem-
ber 2001, November 2002 and December 2004. In 
these years the total number of cases exceeded 
1,300 while, for example, there were fewer 
than a thousand cases in total in 1995–1997. The 
incidence was also low in 2000, with no increase 
even toward the end of the year. After two peak 
winters in 2001 and 2002 the incidence remained 
high almost throughout 2003, and no separate peak 
was seen in December 2003. In 2004, nearly 1,500 
cases of epidemic nephropathy were notifi ed, and 
the incidence peaked again in December.
The regions with a high incidence of epidemic 
nephropathy may vary from year to year depending 
on the bank vole population density. The incidence 
has almost always been highest in the hospital dis-
trict of Etelä-Savo or Itä-Savo (Figure 23). In 2004, 
Figure 23.  Average incidence of Puumala virus cases by 
hospital district 19952004.
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the incidence was highest in the hospital district of 
Itä-Savo (122/100,000 population).
TBE  PRIMARILY IN ÅLAND 
The number of tick-borne encephalitis (TBE) cases 
has increased since the 1990s almost everywhere 
in the Baltic Sea region, and this is also the case in 
Finland (Figure 24). The development is considered 
to be due to the change of climate, which has facili-
tated the circulation of the virus in tick populations. 
In Finland the disease has been traditionally en-
demic for Åland, and cases have also been detected 
in restricted areas on the south, southwest and west 
coast of Finland. There is an effi cient vaccination 
available, and experts have suggested that it should 
be taken into general use in Åland. At the moment 
the vaccination is only administered to people who 
are considered to have an exceptionally high risk of 
becoming infected due to the nature of their work 
or free time activities.
Figure 24.  Tick-borne encephalitis (TBE), Åland and rest of Finland 19952004.
Figure 25.  Average incidence of tularemia cases by hospital 
district 19952004.
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TULAREMIA  FOUR TULAREMIA OUTBREAKS 
DURING THE SURVEILLANCE PERIOD
In 2004, the National Infectious Diseases Regis-
ter received 151 notifi cations of microbiologically 
confi rmed cases of Francisella tularensis (incidence 
2.9/100,000 population/year). The cases were 5–84 
years old (median 50 years), and 55 percent were 
males. The incidence in 2004 was average with re-
spect to the entire surveillance period – normally 
approximately a hundred cases per year are noti-
fi ed (incidence 1–2 cases/100,000/year). The major-
ity of cases were diagnosed between July and Oc-
tober in North and South Pohjanmaa and Central 
Finland in areas where tularemia has traditionally 
been endemic (Figure 25). In recent years, however, 
there have been signs that the geographical region 
endemic for tularemia incidence is expanding to 
the south. Large tularemia outbreaks have occurred 
in 1995 (467 cases), 1996 (397 cases), 2000 (926 cas-
es) and 2003 (823 cases). The ulceroglandular form 
of tularemia is mainly transmitted by insect bites. 
Clusters of the pulmonary form of tularemia have 
been detected in connection with large outbreaks, 
and these cases have been associated to inhaling 
hay dust during harvesting.  
POGOSTA DISEASE  FEWER CASES IN 2004 
THAN BEFORE
In 2004, the National Infectious Diseases Register 
received 40 notifi cations of microbiologically con-
fi rmed Sindbisvirus cases (incidence 0.8/100,000 
population/year). The cases were 11–76 years old 
(median 52 years), and 75 percent were female. In 
2004, the number of notifi ed cases was clearly lower 
than in the preceding years: In 2003, there were 211 
notifi ed cases and in 2002 as many as 597. Most of 
them were detected in August–September in East-
ern Finland in regions where Pogosta disease is tra-
ditionally endemic (Figure 26). The fi rst Pogosta dis-
ease outbreak was detected in Finland in 1974, after 
which outbreaks have recurred every seven years. 
Extensive Pogosta disease outbreaks raged in 1995 
(1,310 cases) and 2002 (597 cases). The outbreaks re-
curring every seven years may be associated with 
local ecological factors and the cyclical variation 
of available host animal populations (forest game 
birds) or vectors.  Sindbisvirus is assumed to be 
transmitted mainly by insect bites. 
LYME DISEASE  HIGH INCIDENCE IN 2004 
The incidence of Lyme disease was exceptionally 
high in 2004. A record-breaking total of 1,135 new 
cases were notifi ed in Finland. 
Figure 26.  Average incidence of Pogosta disease cases 
by hospital district 19952004.
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Åland has a very high incidence Lyme disease 
internationally – in 2004 there were 477 notifi ed 
cases (1,817/100,000 population), which indicates 
an increase of about 75 percent from the previous 
year and represents more than 40 percent of all cas-
es in the whole country. In the rest of Finland the 
number of notifi ed cases increased by 20–50 per-
cent from the previous year. In proportion with the 
population, in 2004 the number of new notifi ed bor-
reliosis cases in the province of Southern Finland 
was more than double (19/100,000) the number of 
cases in the province of Western Finland (8/100,000 
population). In 2004, the incidence peaked in Au-
gust–November.
Increasing incidence with Åland in the lead 
The incidence of Lyme disease has increased 
during the ten-year-period. In 2004, the incidence 
was exceptionally high, which was probably due 
to the very rainy summer. 
The incidence is about 17 cases per 100,000 
population per year. Åland is by far in the lead as 
regards incidence, with an average of 1,343/100,000 
population per year in 2000–2004 (increase 3% com-
pared with 1997–1999). Åland’s proportion of all 
cases notifi ed in Finland was 40 percent during the 
latter half of the ten-year-period, while it was 18 
percent during the fi rst half. In continental Finland, 
in the province of Western Finland the average inci-
dence was 14 notifi ed cases/100,000 population per 
year in 2000–2004 (increase 72%  percent in com-
parison with the years 1997–1999). In the province 
of Southern Finland the average incidence in 2000–
2004 was 7  cases/100,000 population per year (in-
crease 3% from the years 1997–1999). In the prov-
ince of Eastern Finland the incidence has increased 
less rapidly than elsewhere in Finland, and in 2000–
2004 the average incidence was 13  cases/100,000 
population per year (increase 32% from the years 
1997–1999). During the latter half of the ten-year-
period the incidence was higher in Southern and 
Western Finland than in Eastern Finland, while 
during the fi rst part of the period the incidence was 
clearly higher in Eastern Finland compared with 
the provinces of Southern and Western Finland. In 
the province of Oulu there have been just over ten 
cases per year, and a couple of cases a year have 
been notifi ed in the province of Lapland.   
Throughout the ten-year surveillance period 
the incidence has usually peaked in September, ex-
cept in 1996 (August), 2001 (August) and 2003 (Oc-
tober). In November the incidence has always been 
higher than in June – sometimes even more than 
twice as high. 
Figure 27.  Average incidence of Lyme disease cases by 
hospital district 19952004.
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Type 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Plasmodium vivax 5 14 16 6 8 8 16 6 7 5
Plasmodium ovale 3 8 8 4 4 3 6 3 - 2
Plasmodium malariae - 2 2 1 1 1 - - - -
Plasmodium falciparum 24 21 31 27 16 25 16 21 15 20
UnidentiÞ ed Plasmodium - 2 2 3 - 1 - 1 - -
Total 32 47 59 41 29 38 38 31 22 27
Favourable humidity conditions for ticks, vari-
ations in animal reservoirs and the amount of time 
people spend out in the nature have an effect on 
the incidence of borreliosis. 
Regionally the increase has been most inten-
sive in Åland and the province of Southern Finland, 
but an increasing trend has been detected in all 
regions except the provinces of Oulu and Lapland 
with only a few sporadic cases. It is diffi cult 
to specify an exact geographical border for the 
occurrence of Lyme disease in the north. As 
regards the different diseases transmitted by ticks, 
the number of TBE virus infections causing tick-
borne encephalitis has tripled during the ten-
year-period, while the number of Lyme disease 
infections has nearly doubled (Figure 27).
MALARIA  HALF OF THE CASES ARE FINNS 
In 2004, malaria was diagnosed in 26 persons in 
Finland, and in addition two vivax malaria relapses 
were detected. As earlier, the majority of cases, 20 
(77%), were caused by Plasmodium falciparum, all 
of which had origins in tropical Africa (Table 18).  
Fourteen cases had acquired the P. falciparum 
infection in West Africa, four in East Africa and two 
in Southern Africa. One case infected in Nigeria 
had a double infection: in addition to P. falciparum, 
this case was also infected by P. ovale. Altogether 
fi ve Plasmodium vivax infections were detected, one 
from Ethiopia, Sudan, Mali, India and Brazil each. 
One case had been infected by Plasmodium ovale in 
Cameroon. In total, 92 percent of the new malaria 
cases had been acquired in tropical Africa (Figure 
28).
Vivax malaria recurred in two patients even 
though they had received proper primaquine treat-
ment in the year before in order to destroy any la-
tent liver forms of vivax malaria acquired in Papua 
New Guinea. Primaquine resistance is known to oc-
cur in the region.
Half of the cases were Finns and half were 
foreigners, as in previous years. Twelve of the Finns 
had gone to a malaria-endemic region on a trip of 
less than six months. Two were Finns residing in a 
malaria-endemic region. Twelve cases were immi-
grants. Five of them came from a malaria-endem-
ic region and they fell ill soon after arriving in Fin-
land. Seven had lived in Finland for years and had 
gone to visit their former home country. 
Most cases (21 patients, 81%) had taken no 
malaria prophylaxis or had taken it irregularly.
 Vivax and ovale malaria can cause illness 
months or years after the infection due to latent 
parasites in the liver, regardless of proper prophy-
laxis. A few such cases occur every year, this year 
one P. vivax and one P. ovale infection. With three 
cases there was reason to suspect chloroquinine-
Table 18.  Malaria cases by pathogen type 19952004.
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Nigeria 6
Cameroon 3 
Brazil 1
 
Ghana 2 
India 1 
South
America
1
Africa
23 Sudan 2 
Liberia 1
Mali 1
Asia
1
Burkina
Faso 1Guinea 2
Botswana 2
Ethiopia 1
Tanzania 1
Kenya 1
resistant falciparum malaria: one had travelled to 
Tanzania and taken chloroquinine and proguanil 
medication, and two had gone to Zambia and taken 
chloroquinine only.
Majority of cases from Africa in 19952004 
In the past ten-year period the number of malaria 
infections was highest in 1997 with 59 diagnosed 
cases, after which the number has varied between 
30 and 40, but in the last couple of years there have 
been clearly fewer than thirty cases per year. Most 
of these are falciparum malaria cases, and the ma-
jority of all cases have been acquired in Africa.
 Some of the cases are refugees, asylum seek-
ers, adopted children or other immigrants recent-
ly arrived in Finland. A consistent risk group from 
year to year are immigrants from malaria-endemic 
regions who visit their former home country, often 
in West Africa, without taking malaria prophylaxis. 
Most malaria cases, however, are Finns who 
have been on a short trip to a malaria-endemic re-
Figure 28.  Malaria cases detected in Finland in 2004 by country of acquisition. The country of origin of two malaria cases diagnosed 
in Finland is not known. 
The area of distribution of malaria 2002
(source: Matkailijan terveysopas 2004, http://www.ktl.Þ )
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gion and have ignored prophylaxis totally or have 
taken it irregularly or used ineffective prophylaxis.
 Chloroquinine alone or in combination 
with proguanil does not provide suffi cient protec-
tion against malaria in Africa and in other regions 
with resistant malaria. In such regions the recom-
mended prophylaxis is mefl oquine, and should this 
be unsuitable, the alternative is a combination of 
atovaquone and proguanil (Malarone), or doxycy-
cline. The decreased number of malaria patients in 
recent years is hopefully a sign of increasing use of 
effi cient malaria prophylaxis. 
ENTEROVIRUSES 
The offi cial taxonomy of enteroviruses changed 
between 1995 and 2004. The enterovirus genus is 
now divided into fi ve species, comprising Human 
enteroviruses A–D (abbreviated HEV-A – HEV-D) 
and Poliovirus as the fi fth species. The old sub-
group names are still in use in serotype nomencla-
ture. Enteroviruses cause, for example, infections of 
the central nervous system (aseptic meningitis, en-
cephalitis, myelitis, neuritis, etc.), myocarditis and 
typical enterovirus diseases (hand, foot and mouth 
disease, epidemic myalgia, etc.). The notifi cations to 
the National Infectious Diseases Register do not in-
clude data on the clinical presentation. 
Incidence peak in autumn
During the reporting period 1995–2004, altogeth-
er 1,373 laboratory-confi rmed enterovirus infec-
tions were notifi ed to the National Infectious Dis-
eases Register; approximately 60 percent of the 
cases were male. In addition to the item “entero-
virus”, this fi gure also includes all the tradition-
al subgroups, i.e., polio-, coxsackie- and echovirus 
infections. The annual variation in the number of 
fi ndings is considerable (Figure 29). This is partly 
Figure 29.  Cases of enterovirus infection 19952004.
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explained by outbreaks, for example the echovirus 
30 outbreak in 1996. On the other hand, one rea-
son may also be the varying activity in sample tak-
ing, regulated by clinical-epidemiological research 
projects.
The most remarkable technical change dur-
ing the period was the increased use of the RT-PCR 
method in addition to or instead of virus culture. 
Like conventional serology, ordinary enterovirus 
RT-PCR does not separate subgroups and sero-
types. In some cases, for example in the diagnostics 
of aseptic meningitis, RT-PCR is clearly more sensi-
tive than virus culture in detecting the virus 
in cerebrospinal fl uid. Virus culture of stool is a 
useful method for monitoring the possible circula-
tion of polioviruses in the population; this surveil-
lance is still necessary in Finland. 
Upper respiratory tract infection is an addi-
tion to the list of “typical” enterovirus diseases as 
a result of the introduction of the RT-PCR method. 
The implementation of RT-PCR has revealed their 
common occurrence. The ordinary enterovirus 
RT-PCR also amplifi es rhinovirus sequences. Sepa-
ration is not always performed, and the results of 
additional tests are not always unambiguous. 
Even though enterovirus infections occur 
around the year, autumn is typically the peak sea-
son for enteroviruses in Finland. Individual studies 
have reported that enteroviruses are found also 
in winter, particularly in the airways, and this 
observation is reinforced by the data obtained 
during the surveillance. The monthly distribution 
of all fi ndings follows the “enterovirus” fi ndings 
in 1999–2002, when their proportion in the entire 
data was at highest. An autumnal peak can still be 
detected, but it is not as distinct as in the echovirus 
30 epidemic in 1996–1997.
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BLOOD CULTURE FINDINGS IN CHILDREN
Serious bacterial infections in children are consist-
ently rare in Finland. The Hib vaccine has practical-
ly eradicated serious Hib infections (Haemophilus 
infl uenzae type b). In addition, this vaccination has 
reduced the total number of positive fi ndings in 
cerebrospinal fl uid and blood cultures. The concern 
of an increase in other serious Haemofi lus infl uen-
zae infections along with the implementation of 
Hib vaccinations has not been realised. As there 
have been no outbreaks of meningococcal infection, 
the situation has been relatively calm. 
During the 10-year surveillance period, more 
than 550 eases with positive blood culture fi ndings 
per year have been detected in children under 15 
years of age. In 2004, the number of positive blood-
culture fi ndings was record-breaking, 636. Only 
once before, in 2002, there were more than six 
hundred cases (626). The most common fi nding 
was Staphylococcus epidermidis or some other 
coagulase-negative staphylococcus. Treatment pro-
cedures related to intensive care, particularly can-
nulas and foreign bodies that remain in the body 
for a longer period of time, increase the susceptibil-
ity to these bacteria. In 2004, there were 187 such 
cases, 132 in the preceding year and 173 in 2002. 
In 1995–2000, a coagulase-negative staphylococcus 
in blood was notifi ed 92–142 times. Coagulase-
negative staphylococci were detected particularly 
in neonates and premature babies. 
The other most common blood culture fi nd-
ings in 2004 included pneumococcus, Streptococcus 
pneumoniae (116), most of which (82) were detect-
ed in its typical age group 1–5 years, Staphylococ-
cus aureus particularly in the age group 6–14 years. 
Findings of Escherichia coli, a common cause of 
FINDINGS IN BLOOD 
AND CEREBROSPINAL FLUID
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 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Microbe / microbial group          
Bacteria          
Staphylococcus, other than aureus, or unindentiÞ ed 54 56 59 64 86 76 100 117 85 155
Streptococcus agalactiae 45 50 42 48 42 38 41 46 37 44
Escherichia coli 52 38 40 48 39 43 39 40 39 37
Staphylococcus aureus 27 22 22 33 29 17 17 24 21 32
Streptococcus pneumoniae 21 11 14 17 16 28 15 12 23 28
Streptococcus viridans group and unindentiÞ ed 11 10 9 6 13 7 11 9 12 15
Enterococci 15 15 9 12 8 8 7 13 13 13
Klebsiella species 5 12 8 8 10 9 8 7 8 9
Enterobacter species 9 5 7 7 10 6 6 6 6 5
Neisseria meningitidis 3 6 2 5 4 8 3 2 2 5
Serratia species 1 - - 1 - 3 - 5 2 4
Pseudomonas species 0 2 3 3 - - 2 1 1 4
Streptococcus pyogenes 2 - 1 1 2 1 2 1 1 3
Streptococcus, other betahaemolytic 2 - 1 5 - 1 0 1 1 2
Bacillus 2 1 1 1 - 1 2 - 1 2
Acinetobacter species 4 1 1 3 2 1 0 4 3 1
Haemophilus species - 3 - 3 - 2 3 - 3 1
Corynebacterium species - - - 1 - 1 1 - 1 1
Clostridium species 2 - 2 1 1 - 1 1 - 1
Proteus species 1 1 - - 2 1 - - - 1
Citrobacter species 3 - 1 2 2 4 2 1 1 -
Stenotrophomonas maltophilia - - - - - - - 1 1 -
Propionibacterium species - - - 3 1 1 - 1 - -
Salmonella species - - - 1 1 - - 1 - -
Bacteroides species - 1 1 1 2 1 1 - - -
Listeria monocytogenes 1 2 1 - - 1 - - - -
Mycobacteria - - - - - - - - - -
Yersinia enterocolitica and pseudotuberculosis 1 - - - - - - - - -
Campylobacter species - - - - - - - - - -
Capnocytophaga canimorsus - - - - - - - - - -
Fusobacterium species - - - - - - - - - -
Other bacteria 2 4 1 3 8 7 3 8 7 6
Bacteria, total 263 240 225 277 282 265 264 301 268 369
          
Fungi          
Candida albicans 5 3 1 3 11 3 3 10 2 3
Other yeasts 1 1 - - 5 9 8 8 2 -
Other fungi - - - - - - - - - -
Fungi, total 6 4 1 3 16 12 11 18 4 3
          
Total number of cases 269 244 226 280 298 277 275 319 272 372
urosepsis, and group G betahaemolytic streptococ-
cus, a bacterium transmitted to the child from the 
mother’s birth canal, were notifi ed almost solely 
in infants under 2 months old. In children aged six 
years or more, in addition to S. aureus fi ndings, the 
most common notifi ed causes of infection in 2004 
were E. coli and pneumococcus. In the preceding 
years in this age group the number of pneumococ-
cal fi ndings was higher than the number of E. coli 
fi ndings. The total number of pneumococcal cases 
did not increase during the surveillance period. 
Meningococci were isolated from blood only 
seven times in 2004; fi ve of these fi ndings were in 
children under one year of age. The total number 
of Pseudomonas aeruginosa fi ndings in the whole 
country was seven, and other gram-negative rods 
Table 19.  Blood culture Þ ndings 19952004, infants (under 1 year of age). 
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 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Microbe / microbial group          
Bacteria          
Streptococcus pneumoniae 71 87 74 60 61 72 76 87 89 88
Staphylococcus aureus 44 35 54 48 57 42 35 58 47 58
Staphylococcus, other than aureus, or unindentiÞ ed 61 36 43 38 55 65 44 57 48 41
Streptococcus viridans group and unindentiÞ ed 23 25 27 26 20 20 23 14 12 18
Escherichia coli 11 11 19 13 14 20 5 13 13 15
Enterococci 6 4 3 2 4 2 4 8 5 6
Klebsiella species 4 1 7 3 4 2 2 6 4 5
Streptococcus pyogenes 2 8 2 10 11 9 9 10 11 4
Pseudomonas species 4 6 7 8 2 7 10 5 7 3
Enterobacter species 4 5 3 3 2 2 - 1 6 3
Stenotrophomonas maltophilia 1 - 6 6 2 2 2 - 1 3
Neisseria meningitidis 3 11 8 9 12 9 9 8 6 2
Bacillus 3 5 4 1 4 9 2 5 6 2
Streptococcus, other beta-haemolytic 1 - - 1 1 1 1 - 3 2
Salmonella species 3 2 1 2 7 1 1 2 2 2
Bacteroides species 1 1 - 2 - 4 1 1 - 2
Acinetobacter species 3 4 3 3 5 5 5 8 2 1
Streptococcus agalactiae 1 2 1 - - 1 - - 2 1
Fusobacterium species 1 6 4 2 5 4 1 3 - 1
Proteus species - - - - 1 - - - - 1
Haemophilus species 2 3 3 2 2 2 2 1 5 -
Clostridium species 2 1 - 3 - 1 - 1 1 -
Corynebacterium species 2 - 1 - 3 3 1 1 1 -
Listeria monocytogenes - - 1 2 - - 1 - 1 -
Propionibacterium species - - 3 - 2 - - - 1 -
Yersinia enterocolitica and pseudotuberculosis 1 - - - - - - - 1 -
Citrobacter species - - 2 - 2 1 1 1 - -
Serratia species 1 1 1 - - - - 1 - -
Campylobacter species - - - - 1 2 1 - - -
Mycobacteria - - - - - - - - - -
Capnocytophaga canimorsus - - - - - - - - - -
Other bacteria 4 7 7 7 11 8 9 13 9 15
Bacteria, total 259 261 284 251 288 294 245 304 283 273
          
Fungi          
Candida albicans 6 1 2 - 2 4 1 2 1 -
Other yeasts 3 2 1 2 4 1 - - - 1
Other fungi - - 3 1 1 - - 1 2 -
Fungi, total 9 3 6 3 7 5 1 3 3 1
          
Total number of cases 268 264 290 254 295 299 246 307 286 274
were detected as sporadic fi ndings in different age 
groups. Streptococcus pyogenes was found in blood 
only six times in 2004, while in previous years the 
number of fi ndings had been approximately double. 
No capsulated haemophili were detected in children 
in 2004 (Table 19–20).
Cerebrospinal ß uid Þ ndings in children
More than 50 bacterial meningitis cases are detect-
ed every year in children under 15 years of age. In 
2004, there were altogether 54 notifi ed cases with 
bacterial fi ndings from cerebrospinal fl uid, the most 
common causes of infection being S. pneumoniae, 
group B streptococcus (GBS, Streptococcus aga-
lactiae) and meningococcus, Neisseria meningitidis. 
Table 20.  Blood culture Þ ndings 19952004, children (114 years).
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 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Microbe / microbial group          
Bacteria          
Streptococcus agalactiae 2 8 2 9 4 4 2 5 1 10
Streptococcus pneumoniae 7 2 2 1 6 1 1 3 6 8
Staphylococcus, other than aureus, or unindentiÞ ed 2 - 3 4 7 5 3 10 4 5
Neisseria meningitidis 2 3 3 2 2 5 4 1 2 4
Staphylococcus aureus 1 1 1 1 - 1 1 - 3 2
Escherichia coli - 1 2 3 1 - 3 1 1 2
Enterococci - - 2 1 1 - - - 1 1
Propionibacterium species - - - - - - - - 1 1
Klebsiella species - - - - - - - 1 - 1
Enterobacter species - - - - - - - - - 1
Streptococcus viridans group and unindentiÞ ed 2 - - 1 - 1 - - 1 -
Haemophilus species 1 1 - 1 - 1 2 - - -
Pseudomonas species - - - 1 - - - - - -
Streptococcus pyogenes - - 1 - - - - - - -
Streptococcus, other beta-haemolytic - - - - - - - - - -
Listeria monocytogenes - - - - - - - - - -
Mycobacteria - - - - - - - - - -
Bacillus - - - - - - - - - -
Corynebacterium species - - - - - - - - - -
Other bacteria - 1 2 - 1 - 1 1 1 1
Bacteria, total 17 17 18 24 22 18 17 22 21 36
          
Fungi          
Candida albicans - - - - - - - - - -
Other yeasts - - - - - - - - - -
Other fungi - - - 1 - - - - - -
Fungi, total - - - 1 - - - - - -
          
Total number of cases 17 17 18 25 22 18 17 22 21 36
There were no notifi ed fi ndings of Hib, Haemophil-
us infl uenzae type b, in cerebrospinal fl uid.  Since 
the mid-1990s, the most common notifi ed bacteri-
al fi nding in children’s cerebrospinal fl uid has been 
meningococcus, with approximately 10 fi ndings 
per year. Last year, however, there were only eight 
such cases, while there were ten notifi ed cases of 
both pneumococcus and GBS. Also in 2003 pneu-
mococcal fi ndings in cerebrospinal fl uid were twice 
as common as meningococcal fi ndings. S. aureus 
in cerebrospinal fl uid was notifi ed in four children, 
and coagulase-negative staphylococcal fi ndings in 
cerebrospinal fl uid was notifi ed in 13; seven of these 
were S. epidermidis. An enterobacterial species was 
detected in the cerebrospinal fl uid of two children 
under 15, and Enterococcus was notifi ed in three 
cases in the entire year.
The GBS fi ndings notifi ed from cerebrospi-
nal fl uid were all from cases under 1 year of age, as 
expected. All but one were less than two months 
old. The number of cases, 10, was the highest in the 
new millennium. Earlier GBS has been detected in 
Table 21.  Cerebrospinal ß uid culture Þ ndings 19952004, infants (under 1 year of age).
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 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Microbe / microbial group          
Bacteria          
Staphylococcus, other than aureus, or unindentiÞ ed - 8 3 4 7 7 2 10 3 6
Neisseria meningitidis 8 6 9 14 9 6 5 7 4 4
Streptococcus pneumoniae 5 6 2 6 6 2 2 1 7 2
Staphylococcus aureus 2 1 6 2 2 1 6 1 2 2
Enterococci - 1 2 - 1 1 - 1 - 2
Streptococcus viridans group and unindentiÞ ed 2 - 1 1 - 1 3 - 1 1
Enterobacter species - - - - - - - - - 1
Haemophilus species 2 - - 2 2 1 1 - 2 -
Mycobacteria - - - - - - - - 1 -
Klebsiella species - - - - - 1 - - 1 -
Streptococcus pyogenes - - - - 1 - 1 1 - -
Streptococcus, other beta-haemolytic - - - - - - - 1 - -
Streptococcus agalactiae - - - - 1 - 1 - - -
Bacillus - - - - - 1 - - - -
Corynebacterium species - - - - - 1 - - - -
Escherichia coli - - - - - 1 - - - -
Listeria monocytogenes - 1 - 1 - - - - - -
Propionibacterium species - - - - - - - - - -
Pseudomonas species - - - - - - - - - -
Other bacteria - 2 - - - 1 3 5 - - 
Bacteria, total 19 25 23 30 29 24 24 27 21 18
          
Fungi          
Candida albicans - - - - - - - - - 1
Other yeasts - - - - - - - - - -
Other fungi - - - - - - - - - -
Fungi, total - - - - - - - - - 1
          
Total number of cases 19 25 23 30 29 24 24 27 21 19
cerebrospinal fl uid in only 1–5 cases per year. The 
number of GBS fi ndings in blood culture has re-
mained relatively stable since the beginning of the 
2000s, at 38–44 cases a year. E.coli meningitis is rare 
today: there were two fi ndings in the cerebrospinal 
fl uid of infants last year, as well as one Serratia and 
one Klebsiella (Table 21 22).
Table 22.  Cerebrospinal ß uid culture Þ ndings 19952004, children (114 years).
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 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Microbe / microbial group          
Bacteria          
Escherichia coli 407 423 498 495 547 532 613 580 645 707
Staphylococcus aureus 279 288 349 340 389 394 437 457 444 484
Staphylococcus, other than aureus, or unindentiÞ ed 265 311 293 342 359 413 421 461 421 435
Streptococcus pneumoniae 221 251 293 283 298 308 342 312 381 387
Streptococcus viridans group and unindentiÞ ed 116 137 140 149 168 171 166 166 174 198
Klebsiella species 92 93 113 106 114 115 114 134 121 159
Enterococci 81 105 121 112 117 111 164 165 145 136
Streptococcus, other beta-haemolytic 40 45 58 59 64 59 66 78 79 102
Streptococcus pyogenes 34 35 55 63 81 84 60 93 78 93
Bacteroides species 64 55 71 68 77 71 70 66 59 73
Streptococcus agalactiae 45 43 53 55 60 63 76 78 68 64
Pseudomonas species 87 73 85 76 71 81 74 76 89 63
Enterobacter species 55 65 78 76 58 75 92 53 60 62
Salmonella species 35 20 14 28 40 21 38 13 25 40
Fusobacterium species 18 14 15 21 21 17 26 15 21 32
Citrobacter species 18 10 15 10 15 19 18 14 10 21
Proteus species 15 11 15 12 10 19 23 15 14 19
Clostridium species 28 20 39 32 28 30 24 18 23 18
Neisseria meningitidis 25 27 9 11 19 13 19 20 18 18
Haemophilus species 5 11 9 14 21 15 22 13 15 17
Acinetobacter species 21 23 16 8 17 18 9 13 10 16
Bacillus 6 15 12 12 8 23 20 18 22 15
Campylobacter species 9 11 8 10 5 11 14 7 10 13
Corynebacterium species 15 14 10 28 14 28 19 23 9 12
Stenotrophomonas maltophilia 14 17 10 7 5 11 15 14 6 12
Serratia species 4 7 11 10 12 8 10 12 14 10
Listeria monocytogenes 11 7 13 24 14 9 7 9 12 7
Propionibacterium species 3 13 15 20 18 20 19 8 11 6
Capnocytophaga canimorsus 4 4 7 3 8 3 6 6 6 6
Yersinia enterocolitica and pseudotuberculosis 1 5 3 4 6 1 3 2 1 1
Mycobacteria 15 10 1 5 - 3 4 2 4 -
Other bacteria 81 69 67 75 79 81 82 99 116 108
Bacteria total 2114 2232 2496 2558 2743 2827 3073 3040 3111 3334
          
Fungi          
Candida albicans 18 32 43 35 36 41 44 29 43 45
Other yeasts 11 13 9 16 18 15 27 23 36 24
Other fungi 3 4 2 11 4 - - 2 1 2
Fungi, total 32 49 54 62 58 56 71 54 80 71
          
Total number of cases 2146 2281 2550 2620 2801 2883 3144 3094 3191 3405
Blood Þ ndings in adults
The total number of cases with positive blood cul-
ture fi ndings in adults increased by nearly 70 per-
cent between 1995 and 2004, from fewer than 5,000 
to nearly 8,000. The increase was greater among 
persons aged 65 or more than among working-age 
adults. There were no signifi cant changes during 
the surveillance period in the proportions of gram-
positive and gram-negative bacteria. Gram-positive 
bacteria are slightly more common in the working-
age population and gram-negative bacteria among 
those aged 65 or more. The proportion of anaerobic 
bacteria of all blood culture fi ndings was four per-
cent and the proportion of fungi was two percent, 
and these proportions did not change.
In 2004, the most common pathogen among 
Table 23.  Blood culture Þ ndings 19952004, working-age population (1564 years).
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 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Microbe / microbial group          
Bacteria          
Escherichia coli 857 951 998 967 1012 1033 1178 1213 1314 1464
Staphylococcus aureus 277 322 322 296 337 396 398 449 466 483
Staphylococcus, other than aureus, or unindentiÞ ed 253 265 256 231 294 372 388 379 370 399
Klebsiella species 143 155 161 177 167 201 241 230 252 341
Enterococci 145 145 140 168 169 210 224 215 241 303
Streptococcus pneumoniae 165 175 196 185 178 189 214 184 220 240
Streptococcus viridans group and unindentiÞ ed 90 86 111 106 110 124 128 121 155 160
Pseudomonas species 138 124 112 103 127 128 135 154 154 141
Streptococcus, other beta-haemolytic 51 80 93 73 97 87 105 100 123 134
Bacteroides species 73 77 99 85 107 103 109 99 122 128
Enterobacter species 39 65 74 83 79 79 97 87 97 91
Proteus species 46 42 47 48 51 65 59 64 70 86
Streptococcus agalactiae 20 39 44 46 51 53 61 49 62 76
Clostridium species 51 46 44 36 40 47 57 47 45 57
Citrobacter species 11 26 18 19 24 26 39 40 44 43
Streptococcus pyogenes 20 17 22 31 22 22 28 46 28 31
Serratia species 12 14 13 18 11 15 30 15 28 18
Listeria monocytogenes 12 16 28 14 23 7 15 11 19 18
Haemophilus species 5 8 10 15 9 17 27 17 14 16
Acinetobacter species 7 10 8 10 7 13 18 17 8 13
Fusobacterium species 5 8 8 13 7 6 6 16 7 13
Corynebacterium species 6 11 9 16 7 21 16 15 7 11
Bacillus 8 2 1 6 7 13 17 11 10 10
Stenotrophomonas maltophilia 6 10 8 1 7 4 8 3 6 10
Propionibacterium species 5 11 20 12 24 19 12 15 4 8
Salmonella species 9 7 8 4 8 5 4 7 6 6
Campylobacter species 3 3 1 1 4 2 3 3 1 5
Neisseria meningitidis 2 3 1 2 3 5 4 4 4 3
Yersinia enterocolitica and pseudotuberculosis 2 3 1 5 2 3 3 2 4 3
Mycobacteria - 1 - 3 - 2 2 1 2 3
Capnocytophaga canimorsus - 1 3 - - 3 1 1 1 1
Other bacteria 65 65 66 78 61 80 67 86 101 130
Bacteria total 2526 2788 2922 2852 3045 3350 3694 3701 3985 4445
          
Fungi          
Candida albicans 28 31 20 24 34 41 48 39 63 50
Other yeasts 17 4 14 15 17 27 22 32 47 27
Other fungi 1 1 2 4 - - 1 - 3 -
Fungi, total 46 36 36 43 51 68 71 71 113 77
          
Total number of cases 2572 2824 2958 2895 3096 3418 3765 3772 4098 4522
working-age adults (15–64 years) was Esherichia 
coli, which constituted a fi fth of all cases based on 
blood culture fi ndings. It was followed by Staphy-
lococcus aureus, coagulase-negative staphylococci, 
Streptococcus pneumoniae, streptococci of the viri-
dans group and Klebsiella species.
Among cases aged 65 years or more, E. coli 
was also by far the most common fi nding, repre-
senting nearly a third of all cases. Next in this age 
group came S. aureus, coagulase-negative staphylo-
cocci, Klebsiella species, Streptococcus pneumoniae 
and enterococci.
In 1995–2004, the number of E. coli and S. 
aureus cases increased equally among those of 
working age and those aged 65 years or more. The 
number of coagulase-negative staphylococci in-
Table 24.  Blood culture Þ ndings 19952004, aged population (65 years and more).
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 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Microbe / microbial group          
Bacteria          
Staphylococcus, other than aureus, or unindentiÞ ed 5 10 8 21 29 29 38 46 32 46
Streptococcus pneumoniae 16 19 21 23 18 16 24 11 21 21
Staphylococcus aureus - 10 5 10 12 11 7 6 10 17
Neisseria meningitidis 34 37 21 18 18 13 12 19 15 12
Propionibacterium species - 1 1 4 2 4 3 6 6 11
Enterococci 1 - 1 4 4 3 4 4 3 7
Enterobacter species 1 - 1 2 1 1 3 1 - 3
Pseudomonas species - - 2 3 5 5 4 5 5 2
Streptococcus agalactiae 1 4 - - 1 - - 1 - 2
Streptococcus viridans group and unindentiÞ ed 1 3 2 6 3 4 3 6 2 1
Listeria monocytogenes 6 2 3 6 2 2 1 - 2 1
Klebsiella species - 1 2 1 2 2 2 2 1 1
Corynebacterium species - - - 2 1 1 2 - 1 1
Streptococcus, other beta-haemolytic - 2 - - 1 - 1 2 - 1
Haemophilus species - 2 2 3 1 3 4 2 - 1
Mycobacteria - - - - - 2 - 2 1 -
Streptococcus pyogenes - - - - - - - 1 1 -
Bacillus - - 1 1 - 2 1 5 - -
Escherichia coli 1 1 2 1 4 2 - 3 - -
Other bacteria 2 3 1 3 3 6 4 5 4 3
Bacteria total 68 95 73 108 107 106 113 127 104 130
          
Fungi          
Candida albicans - - - 1 2 2 - 1 1 2
Other yeasts 1 - - - 2 1 2 1 - 4
Other fungi - - - 1 - - - - - -
Fungi, total 1 - - 2 4 3 2 2 1 6
          
Total number of cases 69 95 73 110 111 109 115 129 105 136
creased slightly more among working-age adults, 
and the number of pneumococcal cases increased 
clearly more among those of working age than 
those aged 65 years or more. As regards the latter 
age group, in addition to the increase in E. coli fi nd-
ings, the number of other enterobacterial fi ndings 
also increased (Klebsiella, Enterobacter and Citro-
bacter species). Enterococcus species, particularly 
E. faecium, increased both among the working-age 
population and the elderly.
The number of ß-haemolytic streptococcus 
fi ndings per year more than doubled among adults 
in 1995–2004. S. pyogens or group A streptococ-
cus increased clearly more strongly among work-
ing-age adults, S. agalactiae or group B streptococ-
cus among those aged 65 years more, and group C 
streptococci increased both among the working-
age population and the elderly.
Candida species increased clearly more 
strongly among the working-age adults than among 
the elderly. The proportion of species other than 
Candida albicans remained between 21 and 42 per-
cent of all Candida fi ndings in 1995–2004, without 
a distinct increase in their proportion. The number 
of Pseudomonas aeruginosa fi ndings remained the 
same, as was also the case with the Acinetobacter 
species (Table 23–24).
Table 25.  Cerebrospinal ß uid culture Þ ndings 19952004, working-age population (1564 years).
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 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Microbe / microbial group          
Bacteria          
Staphylococcus aureus 1 3 4 4 3 2 4 2 7 7
Staphylococcus, other than aureus, or unindentiÞ ed 2 5 5 10 7 5 15 7 5 7
Streptococcus pneumoniae 6 6 4 5 4 6 4 4 5 4
Listeria monocytogenes 3 2 4 4 1 2 3 2 4 2
Escherichia coli 1 - 2 - - 1 1 1 2 2
Neisseria meningitidis 1 2 - 2 1 - 1 - 1 2
Pseudomonas species - - 2 - - - 3 - - 2
Mycobacteria 2 1 1 1 - 2 1 1 4 1
Klebsiella species - 1 2 - - - - - 1 1
Propionibacterium species - - - 1 - - 2 4 - 1
Streptococcus viridans group and unindentiÞ ed - 2 1 - 1 1 1 2 - 1
Enterobacter species - - 1 - - - 1 2 - 1
Enterococci - 1 3 1 - 1 1 3 4 -
Streptococcus, other beta-haemolytic - 2 - - - - 1 - 2 -
Streptococcus agalactiae - - - - - 4 2 - 1 -
Corynebacterium species - - - 1 - - - - 1 -
Bacillus - - - 1 1 1 3 3 - -
Streptococcus pyogenes - - - - - - - 2 - -
Haemophilus species - - 3 - 2 - - - - -
Other bacteria 1 1 1 - - - 1 2 2 -
Bacteria total 17 26 33 30 20 25 44 35 39 31
          
Fungi          
Candida albicans - 1 - - - - - - - -
Other yeasts - 1 - - - - - 2 - 1
Other fungi - - - - - - - - - -
Fungi, total - 2 - - - - - 2 - 1
          
Total number of cases 17 28 33 30 20 25 44 37 39 32
Cerebrospinal ß uid Þ ndings in adults
The number of adult cases with bacterial or fun-
gal fi ndings in the cerebrospinal fl uid doubled from 
1995 to 2004. The increase was slightly stronger 
among those aged 65 or more than among those 
of working-age. The increase among working-age 
adults was mainly due to the increase of coagula-
se-negative staphylococci and Propionibacterium 
species that belong to the normal fl ora of the skin. 
Candida species also increased. Among the elder-
ly there was no single microbe or microbial group 
that explained the increase.
The most common cerebrospinal fl uid fi nd-
ing in working-age adults was coagulase-negative 
staphylococci, followed by the virulent pathogens: 
meningococcus, pneumococcus and S. aureus. 
Meningococcal and pneumococcal fi ndings were 
equal in numbers with the exception of the years 
1995 and 1996 (meningococcal clusters). In 2004, 
S. aureus rose nearly to the same level for the fi rst 
time.
Coagulase-negative staphylococci were the 
most common fi nding also among the elderly, fol-
lowed by pneumococcus, S. aureus and Listeria 
monocytogenes. Pneumococcal and S. aureus fi nd-
ings per year were nearly equal in numbers, and the 
number of L. monocytogenes fi ndings was slightly 
lower (Table 25–26). 
Table 26.  Cerebrospinal ß uid culture Þ ndings 19952004, aged population (65 years and more).
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INFECTIOUS DISEASES IN FINLAND 19952004
CONTRIBUTORS
Introduction Petri Ruutu
Respiratory infections
 Inß uenza A and B Reijo Pyhälä
 Legionella Outi Lyytikäinen and Silja Mentula
 Whooping cough Tea Nieminen
 Mycoplasma Riitta Räty and Marjaana Kleemola
 Chlamydia pneumoniae Maija Leinonen and Mirja Puolakkainen 
 RSV, parainß uenza, adeno Thedi Ziegler and Riitta Räty 
Intestinal infections
 Salmonella Markku Kuusi and Anja Siitonen
 Campylobacter Johanna Takkinen, Markku Kuusi, Anja Siitonen and Ulla-Maija Nakari
 Yersinia Johanna Takkinen and Anja Siitonen
 Shigella Markku Kuusi and Anja Siitonen
 EHEC Markku Kuusi, Anja Siitonen and Marjut Eklund
 Listeria Outi Lyytikäinen, Anja Siitonen and Ulla-Maija Nakari
 Food- and water-born outbreaks Markku Kuusi
 Rota- and Norovirus Markku Kuusi
Hepatitides 
 Hepatitis A Markku Kuusi
 Hepatitis B Tuija Leino
 Hepatitis C Pauli Leinikki
Sexually transmitted diseases
 Chlamydia Eija Hiltunen-Back
 Gonorrhoea Eija Hiltunen-Back
 Syphilis Eija Hiltunen-Back
 HIV and AIDS Mika Salminen and Henrikki Brummer-Korvenkontio
Mycobacterial infections
 Tuberculosis Petri Ruutu
 Molecular epidemiology of tuberculosis Hanna Soini
 Atypical mycobacteria Petri Ruutu
 BCG Ville Postila and Petri Ruutu
Antimicrobial resistance
 MRSA Outi Lyytikäinen and Jaana Vuopio-Varkila
 Pneumococcus Outi Lyytikäinen, Pentti Huovinen and Merja Rantala
 VRE Outi Lyytikäinen and Jaana Vuopio-Varkila
Other infections
 Hib Eija Kela
 Meningococcus Helena Käyhty
 MMR diseases Irja Davidkin
 Puumala virus Mari Kanerva and Outi Lyytikäinen
 Tick-borne encephalitis  TBE Pauli Leinikki
 Pogosta disease Pekka Nuorti
 Tularemia Pekka Nuorti
 Lyme disease Ilkka Seppälä and Jarmo Oksi 
 Malaria Heli Siikamäki 
 Enteroviruses Tapani Hovi and Merja Roivainen
Findings in blood and cerebrospinal ß uid
 Findings in children Tea Nieminen
 Findings in adults Peter Klemets and Outi Lyytikäinen
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